SunHao的个人主页 - 老虎社区

SunHao

暂无个人介绍

IP属地：未知

5关注

25粉丝

0主题

0勋章

2021-12-29

Look forward for quarter results

抱歉，原内容已删除

2021-12-27

EV is the next hot cake

抱歉，原内容已删除

2021-12-26

Microsoft's stock is worth to be added to watchlist as well

2 Top Tech Stocks to Buy During a Recession

2021-11-20

Innovation has bought Nvidea to next level !

抱歉，原内容已删除

2021-11-16

Cunsumer's is the best place to protect ourselves from inflation

抱歉，原内容已删除

2021-11-15

Active invesrment is better than passive investment. You may plan to fight with Mr Market ahead

抱歉，原内容已删除

2021-11-14

Phizer is riding on pandamic wave to boost their revenue

Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.

2021-11-13

Hold tight. Its a minor correction

Nvidia shares fell nearly 2% in morning trading

2021-11-13

Tesla's share is overated. Its time to return to its equilibrium price

抱歉，原内容已删除

2021-11-12

Not a wise decision to be made

抱歉，原内容已删除

2021-11-12

Beware on overrated growth stock

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3583127455388557","uuid":"3583127455388557","gmtCreate":1624264092468,"gmtModify":1624264092468,"name":"SunHao","pinyin":"sunhao","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":25,"headSize":5,"tweetSize":11,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.25","exceedPercentage":"60.37%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":692095453,"gmtCreate":1640788804584,"gmtModify":1640788804866,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583127455388557","idStr":"3583127455388557"},"themes":[],"htmlText":"Look forward for quarter results","listText":"Look forward for quarter results","text":"Look forward for quarter results","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/692095453","repostId":"1190720053","repostType":4,"isVote":1,"tweetType":1,"viewCount":729,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696025438,"gmtCreate":1640579990819,"gmtModify":1640579991096,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583127455388557","idStr":"3583127455388557"},"themes":[],"htmlText":"EV is the next hot cake&nbsp;","listText":"EV is the next hot cake&nbsp;","text":"EV is the next hot cake","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696025438","repostId":"2194855177","repostType":4,"isVote":1,"tweetType":1,"viewCount":716,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698460382,"gmtCreate":1640495308207,"gmtModify":1640500816415,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583127455388557","idStr":"3583127455388557"},"themes":[],"htmlText":"Microsoft's stock is worth to be added to watchlist&nbsp;as well","listText":"Microsoft's stock is worth to be added to watchlist&nbsp;as well","text":"Microsoft's stock is worth to be added to watchlist as well","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698460382","repostId":"2193781141","repostType":4,"repost":{"id":"2193781141","kind":"highlight","pubTimestamp":1640485676,"share":"https://www.laohu8.com/m/news/2193781141?lang=&edition=full","pubTime":"2021-12-26 10:27","market":"us","language":"en","title":"2 Top Tech Stocks to Buy During a Recession","url":"https://stock-news.laohu8.com/highlight/detail?id=2193781141","media":"Motley Fool","summary":"Market crashes are inevitable, but they're the perfect time to buy great businesses at a discount.","content":"<p>We're days away from the end of 2021, and the <b>S&amp;P 500</b> has put on a master class in outperforming expectations. Even with its pullback in recent days, the broad market index has gained nearly 30% this year, more than double its long-term historical average.</p>\n<p>Yet that just means we're another day closer to the inevitable market correction. Just as night follows day, a stock market crash is inevitable because market declines are a natural part of the normal business and investment cycle. No <a href=\"https://laohu8.com/S/AONE.U\">one</a> can forecast exactly when it will strike, but smart investors realize it's best to prepare for the eventuality.</p>\n<p>For as long as people have been investing, stretching even as far back to the Dutch tulip mania in the 1600s, busts have followed booms. And what a boom we've enjoyed! Since the bottom of the Great Recession, the S&amp;P 500 has quadrupled in value.</p>\n<p>2020's pandemic-driven 34% drop in the stock indexes within the span of just a few weeks was the worst on record. But savvy investors don't have to worry. These events are not a problem when you're invested in the right companies. Being prepared for the worst and hoping for the best means when the next stock market crash or correction occurs, you'll want to have your money invested in stocks that will help lead the way forward. Here are two tech stocks you'll want to buy.</p>\n<h2>1. Apple</h2>\n<p>The burden that inflation is imposing on consumers also poses a threat to some of the biggest, best-run businesses, like <b>Apple</b> (NASDAQ:AAPL), which is currently benefiting from the smartphone upgrade cycle and the rollout of 5G network infrastructure. Any attempt by the Federal Reserve to raise interest rates to contain runaway inflation could cause an economic slowdown by making money more expensive to borrow. Stock valuations would also turn lower.</p>\n<p>That's not necessarily bad news for investors who might find Apple's $2.8 trillion valuation a bit rich to buy into at the moment. The stock trades at 30 times trailing earnings, or about double its typical multiple. A correction would bring Apple back into the realm of the attainable, even as its business continues jogging forward.</p>\n<p>Sales of the iPhone 13 are outpacing those of the iPhone 12 at the same time, but Apple reportedly warned suppliers that demand is waning as the calendar year progresses. It's not necessarily for a lack of consumer desire, but rather the global supply chain constraints that have made it difficult to find the product. Apple previously cut its iPhone production target by 10 million units from its original goal of 90 million.</p>\n<p>Analysts think many consumers may choose to forgo the iPhone 13 and wait for the next upgrade. Coupled with a market crash, that could put Apple stock at a very attractive entry point with pent-up demand for the next iteration of the iPhone.</p>\n<h2>2. Amazon</h2>\n<p>Few companies are as essential to the working of the U.S. economy as <b>Amazon</b>&nbsp;(NASDAQ:AMZN). It will account for 41.4% of all online spending in the U.S. this year, according to eMarketer estimates. At the same time, Amazon Web Services (AWS), its cloud infrastructure business, is on track to generate over $60 billion in annual revenue in 2021 based on its year-to-date performance. The company is responsible for thousands of web-based businesses and the federal government's ability to remain online, making Amazon crucial to a well-functioning economy.</p>\n<p>That won't change if the stock market collapses. Its share of U.S. retail e-commerce sales will be more than 50% larger than the shares of the next nine e-commerce companies combined. Amazon's piece of the online market is nearly six times more than <b>Walmart</b>'s second-place share at just 7.2%, and 10 times greater than third-place <b><a href=\"https://laohu8.com/S/EBAY\">eBay</a></b>. E-commerce data tracker Edge by Ascential expects Amazon will see $26.7 billion just in online grocery sales five from now years, or nearly double its current amount.</p>\n<p>Amid rising prices and supply chain woes, Amazon has become a lifeline for many, and that will continue long after any financial restructuring. The stock gained 76% during the first year of the pandemic and took a breather during the reopening of the economy. Amazon shares have been relatively flat all year long. A correction would allow investors to buy a tech stock at a more reasonable valuation even as its crucial role only gets reinforced.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Top Tech Stocks to Buy During a Recession</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Top Tech Stocks to Buy During a Recession\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 10:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/2-top-tech-stocks-to-buy-during-a-recession/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>We're days away from the end of 2021, and the S&P 500 has put on a master class in outperforming expectations. Even with its pullback in recent days, the broad market index has gained nearly 30% ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/2-top-tech-stocks-to-buy-during-a-recession/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4170":"电脑硬件、储存设备及电脑周边","AAPL":"苹果","AMZN":"亚马逊","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4515":"5G概念","BK4553":"喜马拉雅资本持仓","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4524":"宅经济概念","BK4535":"淡马锡持仓","BK4538":"云计算","BK4559":"巴菲特持仓","BK4527":"明星科技股","BK4501":"段永平概念","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","BK4505":"高瓴资本持仓","BK4561":"索罗斯持仓","BK4548":"巴美列捷福持仓"},"source_url":"https://www.fool.com/investing/2021/12/24/2-top-tech-stocks-to-buy-during-a-recession/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193781141","content_text":"We're days away from the end of 2021, and the S&P 500 has put on a master class in outperforming expectations. Even with its pullback in recent days, the broad market index has gained nearly 30% this year, more than double its long-term historical average.\nYet that just means we're another day closer to the inevitable market correction. Just as night follows day, a stock market crash is inevitable because market declines are a natural part of the normal business and investment cycle. No one can forecast exactly when it will strike, but smart investors realize it's best to prepare for the eventuality.\nFor as long as people have been investing, stretching even as far back to the Dutch tulip mania in the 1600s, busts have followed booms. And what a boom we've enjoyed! Since the bottom of the Great Recession, the S&P 500 has quadrupled in value.\n2020's pandemic-driven 34% drop in the stock indexes within the span of just a few weeks was the worst on record. But savvy investors don't have to worry. These events are not a problem when you're invested in the right companies. Being prepared for the worst and hoping for the best means when the next stock market crash or correction occurs, you'll want to have your money invested in stocks that will help lead the way forward. Here are two tech stocks you'll want to buy.\n1. Apple\nThe burden that inflation is imposing on consumers also poses a threat to some of the biggest, best-run businesses, like Apple (NASDAQ:AAPL), which is currently benefiting from the smartphone upgrade cycle and the rollout of 5G network infrastructure. Any attempt by the Federal Reserve to raise interest rates to contain runaway inflation could cause an economic slowdown by making money more expensive to borrow. Stock valuations would also turn lower.\nThat's not necessarily bad news for investors who might find Apple's $2.8 trillion valuation a bit rich to buy into at the moment. The stock trades at 30 times trailing earnings, or about double its typical multiple. A correction would bring Apple back into the realm of the attainable, even as its business continues jogging forward.\nSales of the iPhone 13 are outpacing those of the iPhone 12 at the same time, but Apple reportedly warned suppliers that demand is waning as the calendar year progresses. It's not necessarily for a lack of consumer desire, but rather the global supply chain constraints that have made it difficult to find the product. Apple previously cut its iPhone production target by 10 million units from its original goal of 90 million.\nAnalysts think many consumers may choose to forgo the iPhone 13 and wait for the next upgrade. Coupled with a market crash, that could put Apple stock at a very attractive entry point with pent-up demand for the next iteration of the iPhone.\n2. Amazon\nFew companies are as essential to the working of the U.S. economy as Amazon (NASDAQ:AMZN). It will account for 41.4% of all online spending in the U.S. this year, according to eMarketer estimates. At the same time, Amazon Web Services (AWS), its cloud infrastructure business, is on track to generate over $60 billion in annual revenue in 2021 based on its year-to-date performance. The company is responsible for thousands of web-based businesses and the federal government's ability to remain online, making Amazon crucial to a well-functioning economy.\nThat won't change if the stock market collapses. Its share of U.S. retail e-commerce sales will be more than 50% larger than the shares of the next nine e-commerce companies combined. Amazon's piece of the online market is nearly six times more than Walmart's second-place share at just 7.2%, and 10 times greater than third-place eBay. E-commerce data tracker Edge by Ascential expects Amazon will see $26.7 billion just in online grocery sales five from now years, or nearly double its current amount.\nAmid rising prices and supply chain woes, Amazon has become a lifeline for many, and that will continue long after any financial restructuring. The stock gained 76% during the first year of the pandemic and took a breather during the reopening of the economy. Amazon shares have been relatively flat all year long. A correction would allow investors to buy a tech stock at a more reasonable valuation even as its crucial role only gets reinforced.","news_type":1},"isVote":1,"tweetType":1,"viewCount":758,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876744197,"gmtCreate":1637369731357,"gmtModify":1637369731497,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583127455388557","idStr":"3583127455388557"},"themes":[],"htmlText":"Innovation has bought Nvidea to next level !","listText":"Innovation has bought Nvidea to next level !","text":"Innovation has bought Nvidea to next level !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876744197","repostId":"1154597314","repostType":4,"isVote":1,"tweetType":1,"viewCount":1364,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871213197,"gmtCreate":1637073545839,"gmtModify":1637073574526,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583127455388557","idStr":"3583127455388557"},"themes":[],"htmlText":"Cunsumer's is the best place to protect ourselves from inflation&nbsp;","listText":"Cunsumer's is the best place to protect ourselves from inflation&nbsp;","text":"Cunsumer's is the best place to protect ourselves from inflation","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/871213197","repostId":"1135743655","repostType":4,"isVote":1,"tweetType":1,"viewCount":810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873484857,"gmtCreate":1636977061839,"gmtModify":1636977237042,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583127455388557","idStr":"3583127455388557"},"themes":[],"htmlText":"Active invesrment is better than passive investment. You may plan to fight with Mr Market ahead","listText":"Active invesrment is better than passive investment. You may plan to fight with Mr Market ahead","text":"Active invesrment is better than passive investment. You may plan to fight with Mr Market ahead","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873484857","repostId":"2183046479","repostType":4,"isVote":1,"tweetType":1,"viewCount":696,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873965620,"gmtCreate":1636846358632,"gmtModify":1636846358632,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583127455388557","idStr":"3583127455388557"},"themes":[],"htmlText":"Phizer is riding on pandamic wave to boost their revenue&nbsp;","listText":"Phizer is riding on pandamic wave to boost their revenue&nbsp;","text":"Phizer is riding on pandamic wave to boost their revenue","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873965620","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p>\n<p>“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p>\n<p>Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p>\n<p>Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p>\n<p>In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p>\n<p>The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p>\n<p>Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p>\n<p>The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p>\n<p>The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p>\n<p>The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p>\n<p>While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p>\n<p>In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p>\n<p>The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p>\n<p>“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p>\n<p>Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p>\n<p>“[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p>\n<p>The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p>\n<p>“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p>\n<p>Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p>\n<p>“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p>\n<p>Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p>\n<p>“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p>\n<p>That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p>\n<p>Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p>\n<p>Moderna shares are down more than 40% over the past three months.</p>\n<p>As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p>\n<p>When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p>\n<p>That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p>\n<p>Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p>\n<p>Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p>\n<p>An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that...</p>\n\n<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1306,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879433923,"gmtCreate":1636761487567,"gmtModify":1636761487620,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583127455388557","idStr":"3583127455388557"},"themes":[],"htmlText":"Hold tight. Its a minor correction&nbsp;","listText":"Hold tight. Its a minor correction&nbsp;","text":"Hold tight. Its a minor correction","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/879433923","repostId":"1139324750","repostType":4,"repost":{"id":"1139324750","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636729318,"share":"https://www.laohu8.com/m/news/1139324750?lang=&edition=full","pubTime":"2021-11-12 23:01","market":"us","language":"en","title":"Nvidia shares fell nearly 2% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1139324750","media":"Tiger Newspress","summary":"Nvidia shares fell nearly 2% in morning trading.Wedbush analyst Matt Bryson downgraded NVIDIA Corp t","content":"<p>Nvidia&nbsp;shares&nbsp;fell&nbsp;nearly&nbsp;2%&nbsp;in&nbsp;morning&nbsp;trading.<img src=\"https://static.tigerbbs.com/11eee16e740f662501f2bc3de305f18c\" tg-width=\"871\" tg-height=\"618\" width=\"100%\" height=\"auto\"><b>Wedbush</b>&nbsp;analyst Matt Bryson downgraded&nbsp;<b>NVIDIA Corp</b>&nbsp;to Neutral from&nbsp;Outperform with a price target of $300, up from $220.</p>\n<p>The analyst cites valuation for the downgrade, with the shares trading at 55 times his 2024 numbers.</p>\n<p>He would have to lift the multiple to 67x to justify Outperform, suggesting Nvidia valued at ~7X its stated 2024 TAM and ~25X sales. Conversely, he would have to double his sales growth assumptions (from ~20% to ~40%) over the next couple of years to continue to use a 40X multiple to value Nvidia.</p>\n<p>However, Bryson believes the combination of \"unprecedented demand\" for both data center and client offerings will allow Nvidia to exceed expectations again next week when its reports.</p>\n<p>Nvidia's continued work in building out its AI software will further solidify its AI leadership.</p>\n<p>Client GPUs have again become difficult to source, helped by a combination of solid gaming demand and crypto mining requirements.</p>\n<p>New opportunities, particularly the Metaverse and its graphics-intensive requirements, have started to realize the increased investment.</p>\n<p>He sees no \"negative catalyst\" for the stock and improving fundamentals for Nvidia but downgrades the shares on valuation.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia shares fell nearly 2% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia shares fell nearly 2% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-12 23:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nvidia&nbsp;shares&nbsp;fell&nbsp;nearly&nbsp;2%&nbsp;in&nbsp;morning&nbsp;trading.<img src=\"https://static.tigerbbs.com/11eee16e740f662501f2bc3de305f18c\" tg-width=\"871\" tg-height=\"618\" width=\"100%\" height=\"auto\"><b>Wedbush</b>&nbsp;analyst Matt Bryson downgraded&nbsp;<b>NVIDIA Corp</b>&nbsp;to Neutral from&nbsp;Outperform with a price target of $300, up from $220.</p>\n<p>The analyst cites valuation for the downgrade, with the shares trading at 55 times his 2024 numbers.</p>\n<p>He would have to lift the multiple to 67x to justify Outperform, suggesting Nvidia valued at ~7X its stated 2024 TAM and ~25X sales. Conversely, he would have to double his sales growth assumptions (from ~20% to ~40%) over the next couple of years to continue to use a 40X multiple to value Nvidia.</p>\n<p>However, Bryson believes the combination of \"unprecedented demand\" for both data center and client offerings will allow Nvidia to exceed expectations again next week when its reports.</p>\n<p>Nvidia's continued work in building out its AI software will further solidify its AI leadership.</p>\n<p>Client GPUs have again become difficult to source, helped by a combination of solid gaming demand and crypto mining requirements.</p>\n<p>New opportunities, particularly the Metaverse and its graphics-intensive requirements, have started to realize the increased investment.</p>\n<p>He sees no \"negative catalyst\" for the stock and improving fundamentals for Nvidia but downgrades the shares on valuation.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139324750","content_text":"Nvidia shares fell nearly 2% in morning trading.Wedbush analyst Matt Bryson downgraded NVIDIA Corp to Neutral from Outperform with a price target of $300, up from $220.\nThe analyst cites valuation for the downgrade, with the shares trading at 55 times his 2024 numbers.\nHe would have to lift the multiple to 67x to justify Outperform, suggesting Nvidia valued at ~7X its stated 2024 TAM and ~25X sales. Conversely, he would have to double his sales growth assumptions (from ~20% to ~40%) over the next couple of years to continue to use a 40X multiple to value Nvidia.\nHowever, Bryson believes the combination of \"unprecedented demand\" for both data center and client offerings will allow Nvidia to exceed expectations again next week when its reports.\nNvidia's continued work in building out its AI software will further solidify its AI leadership.\nClient GPUs have again become difficult to source, helped by a combination of solid gaming demand and crypto mining requirements.\nNew opportunities, particularly the Metaverse and its graphics-intensive requirements, have started to realize the increased investment.\nHe sees no \"negative catalyst\" for the stock and improving fundamentals for Nvidia but downgrades the shares on valuation.","news_type":1},"isVote":1,"tweetType":1,"viewCount":932,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879430647,"gmtCreate":1636761336883,"gmtModify":1636761336883,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583127455388557","idStr":"3583127455388557"},"themes":[],"htmlText":"Tesla's share is overated. Its time to return to its equilibrium price&nbsp;","listText":"Tesla's share is overated. Its time to return to its equilibrium price&nbsp;","text":"Tesla's share is overated. Its time to return to its equilibrium price","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/879430647","repostId":"2183501235","repostType":4,"isVote":1,"tweetType":1,"viewCount":659,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879623208,"gmtCreate":1636719986645,"gmtModify":1636719986645,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583127455388557","idStr":"3583127455388557"},"themes":[],"htmlText":"Not a wise decision to be made","listText":"Not a wise decision to be made","text":"Not a wise decision to be made","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/879623208","repostId":"2182100092","repostType":4,"isVote":1,"tweetType":1,"viewCount":780,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879029716,"gmtCreate":1636672233259,"gmtModify":1636672233320,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583127455388557","idStr":"3583127455388557"},"themes":[],"htmlText":"Beware on overrated growth stock","listText":"Beware on overrated growth stock","text":"Beware on overrated growth stock","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879029716","repostId":"2182106301","repostType":4,"isVote":1,"tweetType":1,"viewCount":112,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":879430647,"gmtCreate":1636761336883,"gmtModify":1636761336883,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583127455388557","authorIdStr":"3583127455388557"},"themes":[],"htmlText":"Tesla's share is overated. Its time to return to its equilibrium price&nbsp;","listText":"Tesla's share is overated. Its time to return to its equilibrium price&nbsp;","text":"Tesla's share is overated. Its time to return to its equilibrium price","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/879430647","repostId":"2183501235","repostType":4,"repost":{"id":"2183501235","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1636757850,"share":"https://www.laohu8.com/m/news/2183501235?lang=&edition=full","pubTime":"2021-11-13 06:57","market":"us","language":"en","title":"Wall Street ends higher with boost from big tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2183501235","media":"Reuters","summary":"* Johnson & Johnson announces to split into two companies\n* Consumer sentiment hits 10-year low\n* Te","content":"<p>* Johnson &amp; Johnson announces to split into two companies</p>\n<p>* Consumer sentiment hits 10-year low</p>\n<p>* Tesla slides as Musk sells more shares</p>\n<p>* Indexes up: Dow 0.50%, S&amp;P 0.72%, Nasdaq 1.00%</p>\n<p>NEW YORK, Nov 12 (Reuters) - Wall Street stocks closed higher on Friday, with market-leading growth shares kick-starting indexes' climb as investors looked past disappointing U.S. economic data.</p>\n<p>Despite their advances, all three major U.S. stock indexes ended the session below last Friday's close, ending a five-week streak of weekly gains.</p>\n<p>Investors favored growth over value, with megacap tech stocks, led by Apple Inc and Microsoft Corp, doing the heavy lifting.</p>\n<p>The University of Michigan's preliminary consumer sentiment data for November unexpectedly dropped to a 10-year low, and a Labor Department report showed job openings barely budged from record highs even as workers are quitting in record numbers.</p>\n<p>\"Markets drifted higher today despite a very weak consumer sentiment report, as inflation seems to be hurting consumers more than corporate profits,\" said David Carter, chief investment officer at Lenox Wealth Advisors in New York.</p>\n<p>The souring mood of the consumer could be worrisome to retailers as the holiday shopping season draws near, and is likely to draw intensified scrutiny to upcoming retail earnings reports.</p>\n<p>Walmart Inc, Target Corp, Home Depot Inc&nbsp;and Macy's Inc are among the high profile retailers expected to report next week.</p>\n<p>\"Investors will be focused on guidance from retailers to determine if inflation will crimp profit margins or if costs can be passed through,\" Carter added.</p>\n<p>Retail results will herald the last days of what was a largely upbeat third-quarter earnings season. As of Friday, 459 of the companies in the S&amp;P 500 have reported. Of those, 80% delivered consensus-beating earnings, according to Refinitiv.</p>\n<p>The Dow Jones Industrial Average rose 179.08 points, or 0.5%, to 36,100.31. The S&amp;P 500 gained 33.58 points, or 0.72%, at 4,682.85 and the Nasdaq Composite added 156.68 points, or 1%, at 15,860.96.</p>\n<p>Ten of the 11 major sectors of the S&amp;P 500 ended higher, with communications services' 1.7% advance leading gainers. Energy's 0.3% dip represented the largest percentage loss.</p>\n<p>Shares of Johnson &amp; Johnson gained 1.2% after the healthcare giant announced splitting into two companies, dividing its consumer health care segments from its pharmaceuticals/medical devices business.</p>\n<p>Tesla Inc dropped 2.8% on news that Chief Executive Elon Musk has sold an additional $700 million in stock in the next chapter of a saga that began with Musk's infamous <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> poll on whether he should offload shares in the company he founded.</p>\n<p>Rival electric automaker Rivian Automotive Inc advanced 5.7%, notching its third consecutive gain in as many days as a publicly traded company.</p>\n<p>U.S.-listed shares of Alibaba Group Holding slipped 0.6% following the e-commerce giant's report showing its slowest-ever Singles Day sales.</p>\n<p>Advancing issues outnumbered decliners on the NYSE by a 1.29-to-1 ratio; on Nasdaq, a 1.19-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 34 new 52-week highs and one new low; the Nasdaq Composite recorded 130 new highs and 96 new lows.</p>\n<p>Volume on U.S. exchanges was 10.32 billion shares, compared with the 10.94 billion average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends higher with boost from big tech</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends higher with boost from big tech\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-13 06:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Johnson &amp; Johnson announces to split into two companies</p>\n<p>* Consumer sentiment hits 10-year low</p>\n<p>* Tesla slides as Musk sells more shares</p>\n<p>* Indexes up: Dow 0.50%, S&amp;P 0.72%, Nasdaq 1.00%</p>\n<p>NEW YORK, Nov 12 (Reuters) - Wall Street stocks closed higher on Friday, with market-leading growth shares kick-starting indexes' climb as investors looked past disappointing U.S. economic data.</p>\n<p>Despite their advances, all three major U.S. stock indexes ended the session below last Friday's close, ending a five-week streak of weekly gains.</p>\n<p>Investors favored growth over value, with megacap tech stocks, led by Apple Inc and Microsoft Corp, doing the heavy lifting.</p>\n<p>The University of Michigan's preliminary consumer sentiment data for November unexpectedly dropped to a 10-year low, and a Labor Department report showed job openings barely budged from record highs even as workers are quitting in record numbers.</p>\n<p>\"Markets drifted higher today despite a very weak consumer sentiment report, as inflation seems to be hurting consumers more than corporate profits,\" said David Carter, chief investment officer at Lenox Wealth Advisors in New York.</p>\n<p>The souring mood of the consumer could be worrisome to retailers as the holiday shopping season draws near, and is likely to draw intensified scrutiny to upcoming retail earnings reports.</p>\n<p>Walmart Inc, Target Corp, Home Depot Inc&nbsp;and Macy's Inc are among the high profile retailers expected to report next week.</p>\n<p>\"Investors will be focused on guidance from retailers to determine if inflation will crimp profit margins or if costs can be passed through,\" Carter added.</p>\n<p>Retail results will herald the last days of what was a largely upbeat third-quarter earnings season. As of Friday, 459 of the companies in the S&amp;P 500 have reported. Of those, 80% delivered consensus-beating earnings, according to Refinitiv.</p>\n<p>The Dow Jones Industrial Average rose 179.08 points, or 0.5%, to 36,100.31. The S&amp;P 500 gained 33.58 points, or 0.72%, at 4,682.85 and the Nasdaq Composite added 156.68 points, or 1%, at 15,860.96.</p>\n<p>Ten of the 11 major sectors of the S&amp;P 500 ended higher, with communications services' 1.7% advance leading gainers. Energy's 0.3% dip represented the largest percentage loss.</p>\n<p>Shares of Johnson &amp; Johnson gained 1.2% after the healthcare giant announced splitting into two companies, dividing its consumer health care segments from its pharmaceuticals/medical devices business.</p>\n<p>Tesla Inc dropped 2.8% on news that Chief Executive Elon Musk has sold an additional $700 million in stock in the next chapter of a saga that began with Musk's infamous <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> poll on whether he should offload shares in the company he founded.</p>\n<p>Rival electric automaker Rivian Automotive Inc advanced 5.7%, notching its third consecutive gain in as many days as a publicly traded company.</p>\n<p>U.S.-listed shares of Alibaba Group Holding slipped 0.6% following the e-commerce giant's report showing its slowest-ever Singles Day sales.</p>\n<p>Advancing issues outnumbered decliners on the NYSE by a 1.29-to-1 ratio; on Nasdaq, a 1.19-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 34 new 52-week highs and one new low; the Nasdaq Composite recorded 130 new highs and 96 new lows.</p>\n<p>Volume on U.S. exchanges was 10.32 billion shares, compared with the 10.94 billion average over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","TQQQ":"纳指三倍做多ETF","QNETCN":"纳斯达克中美互联网老虎指数","LHDX":"Lucira Health, Inc.","CGEM":"Cullinan Therapeutics","DDM":"道指两倍做多ETF","SH":"标普500反向ETF","DOG":"道指反向ETF","IVV":"标普500指数ETF","LABP":"Landos Biopharma, Inc.","DJX":"1/100道琼斯","APR":"Apria, Inc.","PSQ":"纳指反向ETF","QLD":"纳指两倍做多ETF","09988":"阿里巴巴-W","SANA":"Sana Biotechnology, Inc.","UDOW":"道指三倍做多ETF-ProShares","UPRO":"三倍做多标普500ETF","SSO":"两倍做多标普500ETF","SPXU":"三倍做空标普500ETF","OEF":"标普100指数ETF-iShares","SQQQ":"纳指三倍做空ETF","SDOW":"道指三倍做空ETF-ProShares","QQQ":"纳指100ETF",".DJI":"道琼斯","SDS":"两倍做空标普500ETF","DXD":"道指两倍做空ETF",".IXIC":"NASDAQ Composite","QID":"纳指两倍做空ETF",".SPX":"S&P 500 Index","OEX":"标普100"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2183501235","content_text":"* Johnson & Johnson announces to split into two companies\n* Consumer sentiment hits 10-year low\n* Tesla slides as Musk sells more shares\n* Indexes up: Dow 0.50%, S&P 0.72%, Nasdaq 1.00%\nNEW YORK, Nov 12 (Reuters) - Wall Street stocks closed higher on Friday, with market-leading growth shares kick-starting indexes' climb as investors looked past disappointing U.S. economic data.\nDespite their advances, all three major U.S. stock indexes ended the session below last Friday's close, ending a five-week streak of weekly gains.\nInvestors favored growth over value, with megacap tech stocks, led by Apple Inc and Microsoft Corp, doing the heavy lifting.\nThe University of Michigan's preliminary consumer sentiment data for November unexpectedly dropped to a 10-year low, and a Labor Department report showed job openings barely budged from record highs even as workers are quitting in record numbers.\n\"Markets drifted higher today despite a very weak consumer sentiment report, as inflation seems to be hurting consumers more than corporate profits,\" said David Carter, chief investment officer at Lenox Wealth Advisors in New York.\nThe souring mood of the consumer could be worrisome to retailers as the holiday shopping season draws near, and is likely to draw intensified scrutiny to upcoming retail earnings reports.\nWalmart Inc, Target Corp, Home Depot Inc and Macy's Inc are among the high profile retailers expected to report next week.\n\"Investors will be focused on guidance from retailers to determine if inflation will crimp profit margins or if costs can be passed through,\" Carter added.\nRetail results will herald the last days of what was a largely upbeat third-quarter earnings season. As of Friday, 459 of the companies in the S&P 500 have reported. Of those, 80% delivered consensus-beating earnings, according to Refinitiv.\nThe Dow Jones Industrial Average rose 179.08 points, or 0.5%, to 36,100.31. The S&P 500 gained 33.58 points, or 0.72%, at 4,682.85 and the Nasdaq Composite added 156.68 points, or 1%, at 15,860.96.\nTen of the 11 major sectors of the S&P 500 ended higher, with communications services' 1.7% advance leading gainers. Energy's 0.3% dip represented the largest percentage loss.\nShares of Johnson & Johnson gained 1.2% after the healthcare giant announced splitting into two companies, dividing its consumer health care segments from its pharmaceuticals/medical devices business.\nTesla Inc dropped 2.8% on news that Chief Executive Elon Musk has sold an additional $700 million in stock in the next chapter of a saga that began with Musk's infamous Twitter poll on whether he should offload shares in the company he founded.\nRival electric automaker Rivian Automotive Inc advanced 5.7%, notching its third consecutive gain in as many days as a publicly traded company.\nU.S.-listed shares of Alibaba Group Holding slipped 0.6% following the e-commerce giant's report showing its slowest-ever Singles Day sales.\nAdvancing issues outnumbered decliners on the NYSE by a 1.29-to-1 ratio; on Nasdaq, a 1.19-to-1 ratio favored advancers.\nThe S&P 500 posted 34 new 52-week highs and one new low; the Nasdaq Composite recorded 130 new highs and 96 new lows.\nVolume on U.S. exchanges was 10.32 billion shares, compared with the 10.94 billion average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":659,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879623208,"gmtCreate":1636719986645,"gmtModify":1636719986645,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583127455388557","authorIdStr":"3583127455388557"},"themes":[],"htmlText":"Not a wise decision to be made","listText":"Not a wise decision to be made","text":"Not a wise decision to be made","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/879623208","repostId":"2182100092","repostType":4,"repost":{"id":"2182100092","kind":"news","pubTimestamp":1636718657,"share":"https://www.laohu8.com/m/news/2182100092?lang=&edition=full","pubTime":"2021-11-12 20:04","market":"us","language":"en","title":"Musk Sells More Tesla Stock, Bringing Total to $5.7 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2182100092","media":"Bloomberg","summary":"(Bloomberg) -- Tesla Inc. Chief Executive Officer Elon Musk sold almost $700 million of stock in the","content":"<p>(Bloomberg) -- Tesla Inc. Chief Executive Officer Elon Musk sold almost $700 million of stock in the electric car-maker, continuing a string of transactions that started this week.</p>\n<p>The billionaire on Nov. 11 disposed of 639,737 shares worth about $687 million, according to regulatory filings.</p>\n<p>These latest disposals bring Musk’s total sales this week to approximately $5.7 billion. Some of the trades were made under a pre-arranged trading plan he established in September.</p>\n<p>On Nov. 6, Musk wrote on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> that “much is made lately of unrealized gains being a means of tax avoidance, so I propose selling 10% of my Tesla stock,” and opened a poll allowing users to vote on the matter. Almost 58% of the 3.5 million votes were cast in favor of a sale.</p>\n<p>Tesla stock has slumped 13% this week and slipped 0.4% on Thursday to $1,063.51.</p>\n<p>Musk, 50, is the world’s richest person with a net worth of $294 billion, according to the Bloomberg Billionaires Index.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Musk Sells More Tesla Stock, Bringing Total to $5.7 Billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMusk Sells More Tesla Stock, Bringing Total to $5.7 Billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-12 20:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/musk-sells-more-tesla-stock-115317086.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Tesla Inc. Chief Executive Officer Elon Musk sold almost $700 million of stock in the electric car-maker, continuing a string of transactions that started this week.\nThe billionaire on ...</p>\n\n<a href=\"https://finance.yahoo.com/news/musk-sells-more-tesla-stock-115317086.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://finance.yahoo.com/news/musk-sells-more-tesla-stock-115317086.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2182100092","content_text":"(Bloomberg) -- Tesla Inc. Chief Executive Officer Elon Musk sold almost $700 million of stock in the electric car-maker, continuing a string of transactions that started this week.\nThe billionaire on Nov. 11 disposed of 639,737 shares worth about $687 million, according to regulatory filings.\nThese latest disposals bring Musk’s total sales this week to approximately $5.7 billion. Some of the trades were made under a pre-arranged trading plan he established in September.\nOn Nov. 6, Musk wrote on Twitter that “much is made lately of unrealized gains being a means of tax avoidance, so I propose selling 10% of my Tesla stock,” and opened a poll allowing users to vote on the matter. Almost 58% of the 3.5 million votes were cast in favor of a sale.\nTesla stock has slumped 13% this week and slipped 0.4% on Thursday to $1,063.51.\nMusk, 50, is the world’s richest person with a net worth of $294 billion, according to the Bloomberg Billionaires Index.","news_type":1},"isVote":1,"tweetType":1,"viewCount":780,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879029716,"gmtCreate":1636672233259,"gmtModify":1636672233320,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583127455388557","authorIdStr":"3583127455388557"},"themes":[],"htmlText":"Beware on overrated growth stock","listText":"Beware on overrated growth stock","text":"Beware on overrated growth stock","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879029716","repostId":"2182106301","repostType":4,"repost":{"id":"2182106301","kind":"highlight","pubTimestamp":1636642320,"share":"https://www.laohu8.com/m/news/2182106301?lang=&edition=full","pubTime":"2021-11-11 22:52","market":"us","language":"en","title":"Up 181,000%, Can This Hypergrowth Stock 50x Your Portfolio?","url":"https://stock-news.laohu8.com/highlight/detail?id=2182106301","media":"Motley Fool","summary":"It's impressive the way this supercharged stock is able to mint millionaires.","content":"<p>It's been a dozen years since the end of the Great Recession in 2008 and 2009, and <a href=\"https://laohu8.com/S/AONE.U\">one</a> class of stocks on Wall Street has led an inexorable climb higher: growth stocks.</p>\n<p>Federal Reserve policies around quantitative easing and keeping lending rates artificially low, coupled with massive government spending programs, have created an easy-money environment that's helped fuel the growth of fast-paced businesses. These conditions show little sign of changing anytime soon, and in many respects may accelerate, which makes growth stocks a good bet to continue to outperform the <b>S&amp;P 500</b> over the next decade.</p>\n<p>While the broad market index is setting all-time highs one day after another, one stock, in particular, seems capable of rising above the rest and could help send your portfolio soaring 50 times higher.</p>\n<p>Since going public on May 15, 1997, at $18 per share, or a split-adjusted price of $1.50 per share, <b>Amazon</b>&nbsp;(NASDAQ:AMZN) has been an e-commerce juggernaut, returning over 181,700%. It is now one of the most essential and valuable businesses in existence, with a market cap in excess of $1.8 trillion.</p>\n<p>Over more than two decades, Amazon has expanded beyond its humble origins as an online bookseller to become the internet backbone of many corporations and businesses.</p>\n<p>Yet having achieved such remarkable gains, it's worth asking if it can continue marching skyward. A 50x gain would put its value at some $85 trillion. Possible? Absolutely!</p>\n<h2>One website to rule them all</h2>\n<p>As noted Amazon is the premier e-commerce company, with a recent report from eMarketer suggesting the retail giant could account for 41.4% of all U.S. online retail spending in 2021. That's nearly six times more than <b>Walmart</b>, the company with the second-greatest market share at just 7.2%, and 10 times greater than third-place <b><a href=\"https://laohu8.com/S/EBAY\">eBay</a></b>.</p>\n<p>Or put another way, Amazon's share of U.S. retail e-commerce sales would still be over 50% larger than the share of the next nine companies combined.</p>\n<p>The key to Amazon's retail success is its Prime subscriber service. It has some 200 million members and helps the retailer undercut its brick-and-mortar rival on price and buoy its razor-thin retail margins. Free delivery through the service is just the gateway to the many other services it offers while generating tens of billions of dollars in higher-margin fee revenue.</p>\n<p>It creates incentives for members to shop on the website to get the most out of their annual fee and it has been shown that members spend more than non-Prime customers.</p>\n<h2>Dominating the cloud</h2>\n<p>The real growth opportunity to increasing Amazon's value 50-fold in the coming years is arguably its Amazon Web Services (AWS) cloud-based offering. Already the undisputed leader in cloud infrastructure market share, it's poised to generate over $60 billion in annual run rate revenue based on its performance so far in 2021.</p>\n<p>AWS has long done the heavy lifting in terms of profitability for Amazon, and though its U.S. retail operations have been profitable for a few years now, the cloud services business remains its most profitable segment. Over the first nine months of this year, it has made more than $13.2 billion in operating income, or some 62% of the total.</p>\n<p>AWS is set up to be Amazon's key generator of operating cash flow as it creates vastly superior margins to the retail or advertising arms, even though the revenue it generates is only 13% of the total.</p>\n<p>According to estimates from Canalys, AWS accounts for 32% share of worldwide cloud infrastructure spending.</p>\n<h2>A massive growth opportunity</h2>\n<p>For a 50x return to happen, Amazon's valuation would need to grow from about $1.7 trillion to $85 trillion. While that may sound absurd on its face (remember when Dow 20,000 sounded far-fetched?), it could happen in as few as 25 years at a 16% compound annual growth rate.</p>\n<p>While that may also sound pie-in-the-sky, between Amazon's initial public offering and today, its stock has been growing at a 38% compounded rate. So cutting that expansion rate by more than half still means it's possible, and with its dominating presence in the areas most critical to its success, Amazon.com seems to have a good chance of achieving it.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Up 181,000%, Can This Hypergrowth Stock 50x Your Portfolio?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUp 181,000%, Can This Hypergrowth Stock 50x Your Portfolio?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-11 22:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/11/up-181000-can-this-hypergrowth-stock-50x-your-port/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's been a dozen years since the end of the Great Recession in 2008 and 2009, and one class of stocks on Wall Street has led an inexorable climb higher: growth stocks.\nFederal Reserve policies around...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/11/up-181000-can-this-hypergrowth-stock-50x-your-port/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://www.fool.com/investing/2021/11/11/up-181000-can-this-hypergrowth-stock-50x-your-port/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2182106301","content_text":"It's been a dozen years since the end of the Great Recession in 2008 and 2009, and one class of stocks on Wall Street has led an inexorable climb higher: growth stocks.\nFederal Reserve policies around quantitative easing and keeping lending rates artificially low, coupled with massive government spending programs, have created an easy-money environment that's helped fuel the growth of fast-paced businesses. These conditions show little sign of changing anytime soon, and in many respects may accelerate, which makes growth stocks a good bet to continue to outperform the S&P 500 over the next decade.\nWhile the broad market index is setting all-time highs one day after another, one stock, in particular, seems capable of rising above the rest and could help send your portfolio soaring 50 times higher.\nSince going public on May 15, 1997, at $18 per share, or a split-adjusted price of $1.50 per share, Amazon (NASDAQ:AMZN) has been an e-commerce juggernaut, returning over 181,700%. It is now one of the most essential and valuable businesses in existence, with a market cap in excess of $1.8 trillion.\nOver more than two decades, Amazon has expanded beyond its humble origins as an online bookseller to become the internet backbone of many corporations and businesses.\nYet having achieved such remarkable gains, it's worth asking if it can continue marching skyward. A 50x gain would put its value at some $85 trillion. Possible? Absolutely!\nOne website to rule them all\nAs noted Amazon is the premier e-commerce company, with a recent report from eMarketer suggesting the retail giant could account for 41.4% of all U.S. online retail spending in 2021. That's nearly six times more than Walmart, the company with the second-greatest market share at just 7.2%, and 10 times greater than third-place eBay.\nOr put another way, Amazon's share of U.S. retail e-commerce sales would still be over 50% larger than the share of the next nine companies combined.\nThe key to Amazon's retail success is its Prime subscriber service. It has some 200 million members and helps the retailer undercut its brick-and-mortar rival on price and buoy its razor-thin retail margins. Free delivery through the service is just the gateway to the many other services it offers while generating tens of billions of dollars in higher-margin fee revenue.\nIt creates incentives for members to shop on the website to get the most out of their annual fee and it has been shown that members spend more than non-Prime customers.\nDominating the cloud\nThe real growth opportunity to increasing Amazon's value 50-fold in the coming years is arguably its Amazon Web Services (AWS) cloud-based offering. Already the undisputed leader in cloud infrastructure market share, it's poised to generate over $60 billion in annual run rate revenue based on its performance so far in 2021.\nAWS has long done the heavy lifting in terms of profitability for Amazon, and though its U.S. retail operations have been profitable for a few years now, the cloud services business remains its most profitable segment. Over the first nine months of this year, it has made more than $13.2 billion in operating income, or some 62% of the total.\nAWS is set up to be Amazon's key generator of operating cash flow as it creates vastly superior margins to the retail or advertising arms, even though the revenue it generates is only 13% of the total.\nAccording to estimates from Canalys, AWS accounts for 32% share of worldwide cloud infrastructure spending.\nA massive growth opportunity\nFor a 50x return to happen, Amazon's valuation would need to grow from about $1.7 trillion to $85 trillion. While that may sound absurd on its face (remember when Dow 20,000 sounded far-fetched?), it could happen in as few as 25 years at a 16% compound annual growth rate.\nWhile that may also sound pie-in-the-sky, between Amazon's initial public offering and today, its stock has been growing at a 38% compounded rate. So cutting that expansion rate by more than half still means it's possible, and with its dominating presence in the areas most critical to its success, Amazon.com seems to have a good chance of achieving it.","news_type":1},"isVote":1,"tweetType":1,"viewCount":112,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696025438,"gmtCreate":1640579990819,"gmtModify":1640579991096,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583127455388557","authorIdStr":"3583127455388557"},"themes":[],"htmlText":"EV is the next hot cake&nbsp;","listText":"EV is the next hot cake&nbsp;","text":"EV is the next hot cake","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696025438","repostId":"2194855177","repostType":4,"repost":{"id":"2194855177","kind":"highlight","pubTimestamp":1640575080,"share":"https://www.laohu8.com/m/news/2194855177?lang=&edition=full","pubTime":"2021-12-27 11:18","market":"us","language":"en","title":"4 New Stocks I'll Likely Add to My Portfolio in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2194855177","media":"Motley Fool","summary":"These growth stocks are now a bargain.","content":"<p>New Year, new you, new portfolio additions?</p>\n<p>As we get ready to turn the page on 2021, I can't help but note how we've witnessed a pretty substantial market bifurcation in stocks over the past couple of quarters. Even though the broad market indexes have hit all-time highs, many growth stocks and small-cap plays have entered bear market territory. In other words, plenty of opportunity abounds, even with the major indexes near a record high.</p>\n<p>A number of stocks on my watch list that I've not owned before are getting awfully close to levels where I may not be able to resist buying. Below are four stocks that I believe are likely to find their way into my portfolio in 2022.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/caeb5728f1df2932f1493ee7cf2c6b47\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Nio</h2>\n<p>A year ago, I was completely against electric vehicle (EV) manufacturer <b>Nio</b> (NYSE:NIO). The idea that an unproven automaker kicking out around 20,000 EVs annually could command a $90 billion market cap was so ludicrous that I never thought I'd consider buying it. And yet, here we are.</p>\n<p>Roughly <a href=\"https://laohu8.com/S/AONE.U\">one</a> year later I can say that I am thoroughly impressed with the way Nio's management has ramped up production in the wake of pandemic supply issues and higher inflation. I believe the company's innovation will drive market share gains in China for years to come.</p>\n<p>In terms of production, Nio delivered close to 10,900 EVs in November, which puts it on an extrapolated run-rate pace of 130,000 EVs a year. By the end of next year, the company anticipates an annual run rate of 600,000 EVs. With Nio introducing three new EVs next year, as well as organically growing sales for its existing lineup of SUVs and its crossover EV, it could put <b>Tesla Motors</b>' ramp-up to shame.</p>\n<p>I'm particularly impressed with Nio's battery-as-a-service (BaaS) program. With BaaS, buyers receive a discount on the initial purchase price of their vehicles, and are able to charge, swap, and upgrade their batteries over time. The benefit for Nio is improved customer loyalty to the brand and high-margin fee revenue for years after purchase.</p>\n<p>If there's a pure-play EV maker that has my full and undivided attention, it's Nio.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a2d139c319f85906e1b80a7eb4c15d0c\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Cresco Labs</h2>\n<p>In a market where most growth stocks are still valued at substantive premiums, some of the best deals can be found in the cannabis space. Marijuana stock <b>Cresco Labs</b> (OTC:CRLBF) is one such name that I believe I'll pull the trigger on in 2022.</p>\n<p>To address the elephant in the room anytime pot stocks are discussed, federal legalization would be nice, but it isn't necessary for weed stocks to thrive. With 36 states having legalized cannabis in some capacity, and the federal government allowing individual states to regulate their industries, there's a sizable path for marijuana stocks like Cresco Labs to succeed.</p>\n<p>Like virtually all multi-state operators, Cresco Labs is working on building up its retail presence -- recently opening its 45th location nationwide. However, it's primarily focused on pushing into big-dollar limited-license markets, such as Illinois and Ohio. Markets where regulators purposely limit the number of retail licenses issued ensure that Cresco has a fair shot at building up its brand(s) and garnering a loyal following.</p>\n<p>But the best thing about Cresco Labs is its industry-leading wholesale segment. Wall Street often writes off wholesale cannabis for its poor margins. But when we're talking about a company like Cresco, which holds a cannabis distribution license in California, the biggest pot market in the world, volume makes up for any margin concerns.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a38605bee8e62f3e8aa414fa24278e7e\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Novavax</h2>\n<p>Another high-growth company I'm eyeing that I expect to add to my portfolio at some point in 2022 is biotech stock <b>Novavax</b> (NASDAQ:NVAX).</p>\n<p>Somewhat similar to Nio, I was of the opinion that chasing COVID-19 vaccine stocks at the beginning of 2021 would be a poor move. In many instances, I felt COVID-19 stocks were grossly overpriced, especially not knowing enough about the disease and its variants. After another year of digesting data, I'm ready to crown Novavax as the most attractive COVID-19 play.</p>\n<p>As some of you might already know, Novavax absolutely dazzled with its clinical trial data for NVX-CoV2373. A March-released U.K. study and a June-announced U.S./Mexico trial demonstrated respective vaccine efficacy (VE) of 89.7% and 90.4%. This makes Novavax one of three COVID-19 vaccine producers to hit a 90% VE level, which should allow it to become a key player globally.</p>\n<p>The only reason Novavax's share price didn't blast off into the heavens has been its delays in filing for emergency-use authorization in key markets and production delays. Thankfully, these issues are being pushed into the rearview mirror, and countries are beginning to give Novavax a green light.</p>\n<p>What's more, variants of the disease make it likely that COVID-19 becomes endemic. This suggests Novavax could be a winner from initial inoculations, booster shots, and possibly even combination vaccines with influenza, which the company is developing and testing.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e68ecb34d6e4fd6f7dc599908229a09a\" tg-width=\"700\" tg-height=\"449\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Ping Identity Holdings</h2>\n<p>The fourth and final new stock that I'll likely add to my portfolio in 2022 is cybersecurity play <b>Ping Identity</b> (NYSE:PING).</p>\n<p>There are no shortage of double-digit growth trends investors can put their money to work in right now. But I believe the safest double-digit growth trend throughout the decade is going to be cybersecurity. It's evolved into a basic need service, and more businesses than ever are moving their data, and that of their customers, into the cloud. That's a recipe for success for third-party solution providers like Ping.</p>\n<p>Like most high-performing security offerings, Ping's cloud-based platform is leaning on artificial intelligence. It's effectively becoming smarter at recognizing and responding to threats over time. Where Ping Identity can provide the greatest value is being layered atop on-premises solutions. Ping's infrastructure fills the gaps where on-premises security fails by providing continuous user monitoring, verification, and authorization.</p>\n<p>Ping Identity is also making headway in its push to shift clients away from term-based subscriptions to software-as-a-service (SaaS) subscriptions. The latter should result in higher long-term margins and improved retention rates. Keep in mind that subscription gross margin is already hovering around a juicy 85%.</p>\n<p>Whereas most cybersecurity stocks are still valued at nosebleed sales multiples, Ping is profitable and can be scooped up for about six times Wall Street's estimated sales for 2022. That's a heck of a bargain for what should be a long-term cybersecurity winner.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 New Stocks I'll Likely Add to My Portfolio in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 New Stocks I'll Likely Add to My Portfolio in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 11:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/26/4-new-stocks-ill-likely-add-to-portfolio-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New Year, new you, new portfolio additions?\nAs we get ready to turn the page on 2021, I can't help but note how we've witnessed a pretty substantial market bifurcation in stocks over the past couple ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/26/4-new-stocks-ill-likely-add-to-portfolio-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NGD":"New Gold","NVAX":"诺瓦瓦克斯医药","PING":"Ping Identity Holding","BK4017":"黄金","NIO":"蔚来","CRLBF":"Cresco Labs Inc."},"source_url":"https://www.fool.com/investing/2021/12/26/4-new-stocks-ill-likely-add-to-portfolio-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194855177","content_text":"New Year, new you, new portfolio additions?\nAs we get ready to turn the page on 2021, I can't help but note how we've witnessed a pretty substantial market bifurcation in stocks over the past couple of quarters. Even though the broad market indexes have hit all-time highs, many growth stocks and small-cap plays have entered bear market territory. In other words, plenty of opportunity abounds, even with the major indexes near a record high.\nA number of stocks on my watch list that I've not owned before are getting awfully close to levels where I may not be able to resist buying. Below are four stocks that I believe are likely to find their way into my portfolio in 2022.\nImage source: Getty Images.\nNio\nA year ago, I was completely against electric vehicle (EV) manufacturer Nio (NYSE:NIO). The idea that an unproven automaker kicking out around 20,000 EVs annually could command a $90 billion market cap was so ludicrous that I never thought I'd consider buying it. And yet, here we are.\nRoughly one year later I can say that I am thoroughly impressed with the way Nio's management has ramped up production in the wake of pandemic supply issues and higher inflation. I believe the company's innovation will drive market share gains in China for years to come.\nIn terms of production, Nio delivered close to 10,900 EVs in November, which puts it on an extrapolated run-rate pace of 130,000 EVs a year. By the end of next year, the company anticipates an annual run rate of 600,000 EVs. With Nio introducing three new EVs next year, as well as organically growing sales for its existing lineup of SUVs and its crossover EV, it could put Tesla Motors' ramp-up to shame.\nI'm particularly impressed with Nio's battery-as-a-service (BaaS) program. With BaaS, buyers receive a discount on the initial purchase price of their vehicles, and are able to charge, swap, and upgrade their batteries over time. The benefit for Nio is improved customer loyalty to the brand and high-margin fee revenue for years after purchase.\nIf there's a pure-play EV maker that has my full and undivided attention, it's Nio.\nImage source: Getty Images.\nCresco Labs\nIn a market where most growth stocks are still valued at substantive premiums, some of the best deals can be found in the cannabis space. Marijuana stock Cresco Labs (OTC:CRLBF) is one such name that I believe I'll pull the trigger on in 2022.\nTo address the elephant in the room anytime pot stocks are discussed, federal legalization would be nice, but it isn't necessary for weed stocks to thrive. With 36 states having legalized cannabis in some capacity, and the federal government allowing individual states to regulate their industries, there's a sizable path for marijuana stocks like Cresco Labs to succeed.\nLike virtually all multi-state operators, Cresco Labs is working on building up its retail presence -- recently opening its 45th location nationwide. However, it's primarily focused on pushing into big-dollar limited-license markets, such as Illinois and Ohio. Markets where regulators purposely limit the number of retail licenses issued ensure that Cresco has a fair shot at building up its brand(s) and garnering a loyal following.\nBut the best thing about Cresco Labs is its industry-leading wholesale segment. Wall Street often writes off wholesale cannabis for its poor margins. But when we're talking about a company like Cresco, which holds a cannabis distribution license in California, the biggest pot market in the world, volume makes up for any margin concerns.\nImage source: Getty Images.\nNovavax\nAnother high-growth company I'm eyeing that I expect to add to my portfolio at some point in 2022 is biotech stock Novavax (NASDAQ:NVAX).\nSomewhat similar to Nio, I was of the opinion that chasing COVID-19 vaccine stocks at the beginning of 2021 would be a poor move. In many instances, I felt COVID-19 stocks were grossly overpriced, especially not knowing enough about the disease and its variants. After another year of digesting data, I'm ready to crown Novavax as the most attractive COVID-19 play.\nAs some of you might already know, Novavax absolutely dazzled with its clinical trial data for NVX-CoV2373. A March-released U.K. study and a June-announced U.S./Mexico trial demonstrated respective vaccine efficacy (VE) of 89.7% and 90.4%. This makes Novavax one of three COVID-19 vaccine producers to hit a 90% VE level, which should allow it to become a key player globally.\nThe only reason Novavax's share price didn't blast off into the heavens has been its delays in filing for emergency-use authorization in key markets and production delays. Thankfully, these issues are being pushed into the rearview mirror, and countries are beginning to give Novavax a green light.\nWhat's more, variants of the disease make it likely that COVID-19 becomes endemic. This suggests Novavax could be a winner from initial inoculations, booster shots, and possibly even combination vaccines with influenza, which the company is developing and testing.\nImage source: Getty Images.\nPing Identity Holdings\nThe fourth and final new stock that I'll likely add to my portfolio in 2022 is cybersecurity play Ping Identity (NYSE:PING).\nThere are no shortage of double-digit growth trends investors can put their money to work in right now. But I believe the safest double-digit growth trend throughout the decade is going to be cybersecurity. It's evolved into a basic need service, and more businesses than ever are moving their data, and that of their customers, into the cloud. That's a recipe for success for third-party solution providers like Ping.\nLike most high-performing security offerings, Ping's cloud-based platform is leaning on artificial intelligence. It's effectively becoming smarter at recognizing and responding to threats over time. Where Ping Identity can provide the greatest value is being layered atop on-premises solutions. Ping's infrastructure fills the gaps where on-premises security fails by providing continuous user monitoring, verification, and authorization.\nPing Identity is also making headway in its push to shift clients away from term-based subscriptions to software-as-a-service (SaaS) subscriptions. The latter should result in higher long-term margins and improved retention rates. Keep in mind that subscription gross margin is already hovering around a juicy 85%.\nWhereas most cybersecurity stocks are still valued at nosebleed sales multiples, Ping is profitable and can be scooped up for about six times Wall Street's estimated sales for 2022. That's a heck of a bargain for what should be a long-term cybersecurity winner.","news_type":1},"isVote":1,"tweetType":1,"viewCount":716,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879433923,"gmtCreate":1636761487567,"gmtModify":1636761487620,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583127455388557","authorIdStr":"3583127455388557"},"themes":[],"htmlText":"Hold tight. Its a minor correction&nbsp;","listText":"Hold tight. Its a minor correction&nbsp;","text":"Hold tight. Its a minor correction","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/879433923","repostId":"1139324750","repostType":4,"repost":{"id":"1139324750","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636729318,"share":"https://www.laohu8.com/m/news/1139324750?lang=&edition=full","pubTime":"2021-11-12 23:01","market":"us","language":"en","title":"Nvidia shares fell nearly 2% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1139324750","media":"Tiger Newspress","summary":"Nvidia shares fell nearly 2% in morning trading.Wedbush analyst Matt Bryson downgraded NVIDIA Corp t","content":"<p>Nvidia&nbsp;shares&nbsp;fell&nbsp;nearly&nbsp;2%&nbsp;in&nbsp;morning&nbsp;trading.<img src=\"https://static.tigerbbs.com/11eee16e740f662501f2bc3de305f18c\" tg-width=\"871\" tg-height=\"618\" width=\"100%\" height=\"auto\"><b>Wedbush</b>&nbsp;analyst Matt Bryson downgraded&nbsp;<b>NVIDIA Corp</b>&nbsp;to Neutral from&nbsp;Outperform with a price target of $300, up from $220.</p>\n<p>The analyst cites valuation for the downgrade, with the shares trading at 55 times his 2024 numbers.</p>\n<p>He would have to lift the multiple to 67x to justify Outperform, suggesting Nvidia valued at ~7X its stated 2024 TAM and ~25X sales. Conversely, he would have to double his sales growth assumptions (from ~20% to ~40%) over the next couple of years to continue to use a 40X multiple to value Nvidia.</p>\n<p>However, Bryson believes the combination of \"unprecedented demand\" for both data center and client offerings will allow Nvidia to exceed expectations again next week when its reports.</p>\n<p>Nvidia's continued work in building out its AI software will further solidify its AI leadership.</p>\n<p>Client GPUs have again become difficult to source, helped by a combination of solid gaming demand and crypto mining requirements.</p>\n<p>New opportunities, particularly the Metaverse and its graphics-intensive requirements, have started to realize the increased investment.</p>\n<p>He sees no \"negative catalyst\" for the stock and improving fundamentals for Nvidia but downgrades the shares on valuation.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia shares fell nearly 2% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia shares fell nearly 2% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-12 23:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nvidia&nbsp;shares&nbsp;fell&nbsp;nearly&nbsp;2%&nbsp;in&nbsp;morning&nbsp;trading.<img src=\"https://static.tigerbbs.com/11eee16e740f662501f2bc3de305f18c\" tg-width=\"871\" tg-height=\"618\" width=\"100%\" height=\"auto\"><b>Wedbush</b>&nbsp;analyst Matt Bryson downgraded&nbsp;<b>NVIDIA Corp</b>&nbsp;to Neutral from&nbsp;Outperform with a price target of $300, up from $220.</p>\n<p>The analyst cites valuation for the downgrade, with the shares trading at 55 times his 2024 numbers.</p>\n<p>He would have to lift the multiple to 67x to justify Outperform, suggesting Nvidia valued at ~7X its stated 2024 TAM and ~25X sales. Conversely, he would have to double his sales growth assumptions (from ~20% to ~40%) over the next couple of years to continue to use a 40X multiple to value Nvidia.</p>\n<p>However, Bryson believes the combination of \"unprecedented demand\" for both data center and client offerings will allow Nvidia to exceed expectations again next week when its reports.</p>\n<p>Nvidia's continued work in building out its AI software will further solidify its AI leadership.</p>\n<p>Client GPUs have again become difficult to source, helped by a combination of solid gaming demand and crypto mining requirements.</p>\n<p>New opportunities, particularly the Metaverse and its graphics-intensive requirements, have started to realize the increased investment.</p>\n<p>He sees no \"negative catalyst\" for the stock and improving fundamentals for Nvidia but downgrades the shares on valuation.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139324750","content_text":"Nvidia shares fell nearly 2% in morning trading.Wedbush analyst Matt Bryson downgraded NVIDIA Corp to Neutral from Outperform with a price target of $300, up from $220.\nThe analyst cites valuation for the downgrade, with the shares trading at 55 times his 2024 numbers.\nHe would have to lift the multiple to 67x to justify Outperform, suggesting Nvidia valued at ~7X its stated 2024 TAM and ~25X sales. Conversely, he would have to double his sales growth assumptions (from ~20% to ~40%) over the next couple of years to continue to use a 40X multiple to value Nvidia.\nHowever, Bryson believes the combination of \"unprecedented demand\" for both data center and client offerings will allow Nvidia to exceed expectations again next week when its reports.\nNvidia's continued work in building out its AI software will further solidify its AI leadership.\nClient GPUs have again become difficult to source, helped by a combination of solid gaming demand and crypto mining requirements.\nNew opportunities, particularly the Metaverse and its graphics-intensive requirements, have started to realize the increased investment.\nHe sees no \"negative catalyst\" for the stock and improving fundamentals for Nvidia but downgrades the shares on valuation.","news_type":1},"isVote":1,"tweetType":1,"viewCount":932,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871213197,"gmtCreate":1637073545839,"gmtModify":1637073574526,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583127455388557","authorIdStr":"3583127455388557"},"themes":[],"htmlText":"Cunsumer's is the best place to protect ourselves from inflation&nbsp;","listText":"Cunsumer's is the best place to protect ourselves from inflation&nbsp;","text":"Cunsumer's is the best place to protect ourselves from inflation","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/871213197","repostId":"1135743655","repostType":4,"repost":{"id":"1135743655","kind":"news","pubTimestamp":1637070464,"share":"https://www.laohu8.com/m/news/1135743655?lang=&edition=full","pubTime":"2021-11-16 21:47","market":"us","language":"en","title":"U.S. retail sales beat expectations in October","url":"https://stock-news.laohu8.com/highlight/detail?id=1135743655","media":"Reuters","summary":"U.S. retail sales increased more than expected in October, likely as Americans started their holiday","content":"<p>U.S. retail sales increased more than expected in October, likely as Americans started their holiday shopping early to avoid empty shelves amid shortages of some goods because of the ongoing pandemic, giving the economy a lift at the start of the fourth quarter.</p>\n<p>Retail sales surged 1.7% last month, the Commerce Department said on Tuesday. Data for September was revised higher to show retail sales increasing 0.8% instead of 0.7% as previously reported. Sales have now risen for three straight months.</p>\n<p>Economists polled by Reuters had forecast retail sales advancing 1.4%. Estimates ranged from as low as a 0.1% dip to as high as a 2.8% increase.</p>\n<p>Unit motor vehicle sales increased in October for the first time in six months. The tight supply of automobiles because of a global semiconductor shortage has driven up motor vehicle prices, contributing to the rise in retail sales last month. Retail sales also received a boost from higher gasoline prices.</p>\n<p>Consumer prices soared 0.9% in October. Shortages could have led consumers to anticipate even higher prices and shop early.</p>\n<p>\"Strapped supply and retailers encouraging shoppers to start holiday shopping early suggest some spending was likely brought forward,\" said Sam Bullard, a senior economist at Wells Fargo in Charlotte, North Carolina. \"Regardless, holiday sales are almost certainly going to set a record year-ago gain even as retailers face a unique set of challenges.\"</p>\n<p>The nearly two-year long coronavirus pandemic has caused an acute shortage of labor, delaying deliveries of raw materials to factories as well as shipments of finished goods to markets.</p>\n<p>Excluding automobiles, gasoline, building materials and food services, retail sales shot up 1.6% last month after increasing 0.5% in September. These so-called core retail sales correspond most closely with the consumer spending component of gross domestic product.</p>\n<p>Retail sales are mostly made up of goods, with services, including healthcare, education and hotel accommodation, making up the remaining portion of consumer spending.</p>\n<p>Even when adjusted for inflation, retail sales rose solidly last month, leaving the pace of growth in consumer spending above the meager 1.6% annualized rate logged in the third quarter. The fading headwind from a surge in COVID-19 infections over summer is reviving economic activity.</p>\n<p>The report added to strong employment growth in October and an acceleration in services sector activity in painting an upbeat picture of the economy after GDP increased at a 2.0% rate last quarter, the slowest pace in more than a year.</p>\n<p>Hiring is accompanied by an acceleration in wages as companies scramble to fill 10.4 million open jobs as of the end of September. But high inflation is wiping out those gains for some workers, which helped to sink consumer sentiment to a 10-year low in early November.</p>\n<p>Still, economists do not believe the tumble in sentiment reported by the University of Michigan last Friday will undermine consumer spending, noting that other sentiment measures were above early-pandemic lows. Americans amassed at least $2 trillion in excess savings during the pandemic.</p>\n<p>\"This continuing weakness in confidence does not warrant any immediate change to our near-term forecast for consumer spending since other factors are more important, particularly real disposable income, which is holding steady at a high level,\" said Scott Hoyt, a senior economist at Moody's Analytics in West Chester, Pennsylvania. \"Support also comes from strong job growth, plentiful jobs, and abundant available cash for many.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. retail sales beat expectations in October</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. retail sales beat expectations in October\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-16 21:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/business/us-retail-sales-beat-expectations-october-2021-11-16/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. retail sales increased more than expected in October, likely as Americans started their holiday shopping early to avoid empty shelves amid shortages of some goods because of the ongoing pandemic,...</p>\n\n<a href=\"https://www.reuters.com/business/us-retail-sales-beat-expectations-october-2021-11-16/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.reuters.com/business/us-retail-sales-beat-expectations-october-2021-11-16/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135743655","content_text":"U.S. retail sales increased more than expected in October, likely as Americans started their holiday shopping early to avoid empty shelves amid shortages of some goods because of the ongoing pandemic, giving the economy a lift at the start of the fourth quarter.\nRetail sales surged 1.7% last month, the Commerce Department said on Tuesday. Data for September was revised higher to show retail sales increasing 0.8% instead of 0.7% as previously reported. Sales have now risen for three straight months.\nEconomists polled by Reuters had forecast retail sales advancing 1.4%. Estimates ranged from as low as a 0.1% dip to as high as a 2.8% increase.\nUnit motor vehicle sales increased in October for the first time in six months. The tight supply of automobiles because of a global semiconductor shortage has driven up motor vehicle prices, contributing to the rise in retail sales last month. Retail sales also received a boost from higher gasoline prices.\nConsumer prices soared 0.9% in October. Shortages could have led consumers to anticipate even higher prices and shop early.\n\"Strapped supply and retailers encouraging shoppers to start holiday shopping early suggest some spending was likely brought forward,\" said Sam Bullard, a senior economist at Wells Fargo in Charlotte, North Carolina. \"Regardless, holiday sales are almost certainly going to set a record year-ago gain even as retailers face a unique set of challenges.\"\nThe nearly two-year long coronavirus pandemic has caused an acute shortage of labor, delaying deliveries of raw materials to factories as well as shipments of finished goods to markets.\nExcluding automobiles, gasoline, building materials and food services, retail sales shot up 1.6% last month after increasing 0.5% in September. These so-called core retail sales correspond most closely with the consumer spending component of gross domestic product.\nRetail sales are mostly made up of goods, with services, including healthcare, education and hotel accommodation, making up the remaining portion of consumer spending.\nEven when adjusted for inflation, retail sales rose solidly last month, leaving the pace of growth in consumer spending above the meager 1.6% annualized rate logged in the third quarter. The fading headwind from a surge in COVID-19 infections over summer is reviving economic activity.\nThe report added to strong employment growth in October and an acceleration in services sector activity in painting an upbeat picture of the economy after GDP increased at a 2.0% rate last quarter, the slowest pace in more than a year.\nHiring is accompanied by an acceleration in wages as companies scramble to fill 10.4 million open jobs as of the end of September. But high inflation is wiping out those gains for some workers, which helped to sink consumer sentiment to a 10-year low in early November.\nStill, economists do not believe the tumble in sentiment reported by the University of Michigan last Friday will undermine consumer spending, noting that other sentiment measures were above early-pandemic lows. Americans amassed at least $2 trillion in excess savings during the pandemic.\n\"This continuing weakness in confidence does not warrant any immediate change to our near-term forecast for consumer spending since other factors are more important, particularly real disposable income, which is holding steady at a high level,\" said Scott Hoyt, a senior economist at Moody's Analytics in West Chester, Pennsylvania. \"Support also comes from strong job growth, plentiful jobs, and abundant available cash for many.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":692095453,"gmtCreate":1640788804584,"gmtModify":1640788804866,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583127455388557","authorIdStr":"3583127455388557"},"themes":[],"htmlText":"Look forward for quarter results","listText":"Look forward for quarter results","text":"Look forward for quarter results","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/692095453","repostId":"1190720053","repostType":4,"repost":{"id":"1190720053","kind":"news","pubTimestamp":1640787793,"share":"https://www.laohu8.com/m/news/1190720053?lang=&edition=full","pubTime":"2021-12-29 22:23","market":"us","language":"en","title":"Tech Megacaps Had a Big 2021. What’s Ahead for 2022.","url":"https://stock-news.laohu8.com/highlight/detail?id=1190720053","media":"Barrons","summary":"While the tech megacaps continue to grow in importance in the major stock averages, the market-cap g","content":"<html><head></head><body><p>While the tech megacaps continue to grow in importance in the major stock averages, the market-cap giants have actually had wildly divergent performance in 2021—and their prospects vary considerably for 2022.</p><p>Let’s take a closer look, in size order, at the eight tech stocks with valuations of more than $500 billion.</p><p>Apple (ticker: AAPL) remains the world’s most highly valued company, with a market capitalization just a smidgen shy of $3 trillion. With a year-to-date gain of about 36%, Apple has outperformed both the 27% return on the S&amp;P 500 and the 23% rally on the Nasdaq Composite.</p><p>Most of Apple’s performance was concentrated in the fourth quarter—the stock is up 27% since the end of October, a period in which the S&amp;P 500 rallied a more modest 11%. Several factors appear to be contributing to its strength: Apple continues to report robust growth for the iPhone, Macs, iPads, wearables, and services, all while aggressively repurchasing its own stock. And 2022 is shaping up to be a big year for new products, with growing buzz in particular about the potential launch of a headset for augmented- and virtual-reality applications.</p><p>This year’s rally follows gains of 82% last year and 89% in 2019, which means the stock has rallied 365% over the past three years. Barring a sharp slowdown in iPhone sales, the string should continue in 2022.</p><p>Microsoft (MSFT) had a fantastic year, with the stock up 54% year to date, driving its market cap to $2.56 trillion. The world’s largest software company is producing astonishing growth at scale, with the top line up 22% in the latest quarter. Underlying Microsoft’s strong growth is continued demand for cloud computing—the company’s Azure business expanded 50% in the September quarter.</p><p>Meanwhile, Microsoft is seeing strength in demand for Office, Windows, Xbox, and other parts of its business. With enterprise spending likely to accelerate in 2022, there seems no reason to think that Microsoft’s impressive growth will slow down next year.</p><p>Alphabet shares (GOOGL) have soared 68% so far in 2021, leaving its market cap just shy of $2 trillion. There’s simply no slowdown in demand for online advertising—and the company’s Google unit has largely dodged the pain inflicted on some ad-supported businesses by Apple’s shift to new rules that make it harder to follow customer behavior on iPhones. Search activity isn’t as dependent as display ads for determining consumer intent—and it seems likely that some ad spending is shifting from social media to search-based advertising. Growth is robust, too, in the company’s YouTube business.</p><p>Barring any new regulatory challenges, it seems likely that Alphabet will continue to produce strong growth in 2022—Street consensus estimates call for 17% growth.</p><p>Amazon.com (AMZN) is the clear laggard among the megacaps, with a year-to-date gain of just 5%, leaving the stock with a valuation of $1.74 billion. It’s behaving like an out-of-favor stay-at-home stock—growth in the company’s core e-commerce business has slowed as some shoppers began venturing to physical stores for some purchases. Other elements of the business remain strong, though, including the Amazon Web Services cloud business, logistics and advertising. Investors also factored in the decision by founder Jeff Bezos to step down as CEO, replaced by former AWS chief Andy Jassy.</p><p>One other wild card: New Federal Trade Commission chair Lina Khan has a long track record as an Amazon critic. The FTC has yet to rule on the company’s pending acquisition of the movie studio MGM—nor have they responded on an Amazon request for Khan to recuse herself on all Amazon matters given her previous writings about the company. Despite all of that, after a year of lackluster performance, the stock might be the most appealing of the tech giants for 2022.</p><p>Tesla (TSLA) is back in the 13-digit market-cap club, with a 57% gain for the year, all of that in the year’s second half, including a 16% gain since Dec. 21. Founder and CEO Elon Musk seems to have completed a recent flurry of stock sales, and Street analysts have been ratcheting up both their target prices and their earnings estimates for the electric vehicle leader. Wedbush analyst Dan Ives, who has a $1,400 target on the stock—a potential gain of more than 30%—thinks the key could be demand in China.</p><p>Meta Platforms (FB) is up 22% this year, lifting its market cap to $967 billion, impressive performance after a year in which the company received a blizzard of bad publicity, in particular a scathing Wall Street Journal series called “The Facebook Files,” which levered leaked material to raise myriad questions about the ill effects of the company’s platforms. Meanwhile, Apple’s efforts to prevent consumer activity tracking on iPhones hurt the company’s ability to target advertising, while regulatory pressures on the company continue to mount.</p><p>The company also changed its name and launched a $10 billion investment program focused on the metaverse, a bold call that might not pay off for years, or maybe ever. All that said, Facebook shares look relatively modestly valued compared with other Big Tech names, which makes them an intriguing option.</p><p>Two chip plays have muscled into the megacap discussion.</p><p>Nvidia shares (NVDA) have had a fantastic run, up 132% for the year to date, boosting the company’s valuation to $750 billion. Once viewed mostly as a provider of graphics cards used by gamers, Nvidia is now a key component provider to cloud-computing companies—and a play on almost every key trend in the semiconductor world, including cryptocurrency mining, artificial intelligence and machine learning, electric and autonomous vehicles, and even the metaverse. Revenue in the latest quarter surged 50%. One caveat on Nvidia shares is that the stock trades at 28 times current year estimated revenues—a valuation more often awarded cloud-software stocks than chip makers.</p><p>And then there’s Taiwan Semiconductor (TSM), which has been a laggard, up just 12% for the year despite the huge global appetite for chips. The world’s largest contract chip maker, with a market cap of $635 billion, is building out new facilities in an attempt to catch up with demand, while other players like Samsung Electronics (005930.Korea) and GlobalFoundries (GFS) do the same, and Intel (INTC) likewise is moving into the market.</p></body></html>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tech Megacaps Had a Big 2021. What’s Ahead for 2022.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTech Megacaps Had a Big 2021. What’s Ahead for 2022.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-29 22:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/tech-megacaps-apple-microsoft-alphabet-amazon-whats-ahead-51640716212?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>While the tech megacaps continue to grow in importance in the major stock averages, the market-cap giants have actually had wildly divergent performance in 2021—and their prospects vary considerably ...</p>\n\n<a href=\"https://www.barrons.com/articles/tech-megacaps-apple-microsoft-alphabet-amazon-whats-ahead-51640716212?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","AAPL":"苹果","GOOG":"谷歌","TSLA":"特斯拉","AMZN":"亚马逊","GOOGL":"谷歌A","TSM":"台积电","MSFT":"微软"},"source_url":"https://www.barrons.com/articles/tech-megacaps-apple-microsoft-alphabet-amazon-whats-ahead-51640716212?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190720053","content_text":"While the tech megacaps continue to grow in importance in the major stock averages, the market-cap giants have actually had wildly divergent performance in 2021—and their prospects vary considerably for 2022.Let’s take a closer look, in size order, at the eight tech stocks with valuations of more than $500 billion.Apple (ticker: AAPL) remains the world’s most highly valued company, with a market capitalization just a smidgen shy of $3 trillion. With a year-to-date gain of about 36%, Apple has outperformed both the 27% return on the S&P 500 and the 23% rally on the Nasdaq Composite.Most of Apple’s performance was concentrated in the fourth quarter—the stock is up 27% since the end of October, a period in which the S&P 500 rallied a more modest 11%. Several factors appear to be contributing to its strength: Apple continues to report robust growth for the iPhone, Macs, iPads, wearables, and services, all while aggressively repurchasing its own stock. And 2022 is shaping up to be a big year for new products, with growing buzz in particular about the potential launch of a headset for augmented- and virtual-reality applications.This year’s rally follows gains of 82% last year and 89% in 2019, which means the stock has rallied 365% over the past three years. Barring a sharp slowdown in iPhone sales, the string should continue in 2022.Microsoft (MSFT) had a fantastic year, with the stock up 54% year to date, driving its market cap to $2.56 trillion. The world’s largest software company is producing astonishing growth at scale, with the top line up 22% in the latest quarter. Underlying Microsoft’s strong growth is continued demand for cloud computing—the company’s Azure business expanded 50% in the September quarter.Meanwhile, Microsoft is seeing strength in demand for Office, Windows, Xbox, and other parts of its business. With enterprise spending likely to accelerate in 2022, there seems no reason to think that Microsoft’s impressive growth will slow down next year.Alphabet shares (GOOGL) have soared 68% so far in 2021, leaving its market cap just shy of $2 trillion. There’s simply no slowdown in demand for online advertising—and the company’s Google unit has largely dodged the pain inflicted on some ad-supported businesses by Apple’s shift to new rules that make it harder to follow customer behavior on iPhones. Search activity isn’t as dependent as display ads for determining consumer intent—and it seems likely that some ad spending is shifting from social media to search-based advertising. Growth is robust, too, in the company’s YouTube business.Barring any new regulatory challenges, it seems likely that Alphabet will continue to produce strong growth in 2022—Street consensus estimates call for 17% growth.Amazon.com (AMZN) is the clear laggard among the megacaps, with a year-to-date gain of just 5%, leaving the stock with a valuation of $1.74 billion. It’s behaving like an out-of-favor stay-at-home stock—growth in the company’s core e-commerce business has slowed as some shoppers began venturing to physical stores for some purchases. Other elements of the business remain strong, though, including the Amazon Web Services cloud business, logistics and advertising. Investors also factored in the decision by founder Jeff Bezos to step down as CEO, replaced by former AWS chief Andy Jassy.One other wild card: New Federal Trade Commission chair Lina Khan has a long track record as an Amazon critic. The FTC has yet to rule on the company’s pending acquisition of the movie studio MGM—nor have they responded on an Amazon request for Khan to recuse herself on all Amazon matters given her previous writings about the company. Despite all of that, after a year of lackluster performance, the stock might be the most appealing of the tech giants for 2022.Tesla (TSLA) is back in the 13-digit market-cap club, with a 57% gain for the year, all of that in the year’s second half, including a 16% gain since Dec. 21. Founder and CEO Elon Musk seems to have completed a recent flurry of stock sales, and Street analysts have been ratcheting up both their target prices and their earnings estimates for the electric vehicle leader. Wedbush analyst Dan Ives, who has a $1,400 target on the stock—a potential gain of more than 30%—thinks the key could be demand in China.Meta Platforms (FB) is up 22% this year, lifting its market cap to $967 billion, impressive performance after a year in which the company received a blizzard of bad publicity, in particular a scathing Wall Street Journal series called “The Facebook Files,” which levered leaked material to raise myriad questions about the ill effects of the company’s platforms. Meanwhile, Apple’s efforts to prevent consumer activity tracking on iPhones hurt the company’s ability to target advertising, while regulatory pressures on the company continue to mount.The company also changed its name and launched a $10 billion investment program focused on the metaverse, a bold call that might not pay off for years, or maybe ever. All that said, Facebook shares look relatively modestly valued compared with other Big Tech names, which makes them an intriguing option.Two chip plays have muscled into the megacap discussion.Nvidia shares (NVDA) have had a fantastic run, up 132% for the year to date, boosting the company’s valuation to $750 billion. Once viewed mostly as a provider of graphics cards used by gamers, Nvidia is now a key component provider to cloud-computing companies—and a play on almost every key trend in the semiconductor world, including cryptocurrency mining, artificial intelligence and machine learning, electric and autonomous vehicles, and even the metaverse. Revenue in the latest quarter surged 50%. One caveat on Nvidia shares is that the stock trades at 28 times current year estimated revenues—a valuation more often awarded cloud-software stocks than chip makers.And then there’s Taiwan Semiconductor (TSM), which has been a laggard, up just 12% for the year despite the huge global appetite for chips. The world’s largest contract chip maker, with a market cap of $635 billion, is building out new facilities in an attempt to catch up with demand, while other players like Samsung Electronics (005930.Korea) and GlobalFoundries (GFS) do the same, and Intel (INTC) likewise is moving into the market.","news_type":1},"isVote":1,"tweetType":1,"viewCount":729,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698460382,"gmtCreate":1640495308207,"gmtModify":1640500816415,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583127455388557","authorIdStr":"3583127455388557"},"themes":[],"htmlText":"Microsoft's stock is worth to be added to watchlist&nbsp;as well","listText":"Microsoft's stock is worth to be added to watchlist&nbsp;as well","text":"Microsoft's stock is worth to be added to watchlist as well","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698460382","repostId":"2193781141","repostType":4,"repost":{"id":"2193781141","kind":"highlight","pubTimestamp":1640485676,"share":"https://www.laohu8.com/m/news/2193781141?lang=&edition=full","pubTime":"2021-12-26 10:27","market":"us","language":"en","title":"2 Top Tech Stocks to Buy During a Recession","url":"https://stock-news.laohu8.com/highlight/detail?id=2193781141","media":"Motley Fool","summary":"Market crashes are inevitable, but they're the perfect time to buy great businesses at a discount.","content":"<p>We're days away from the end of 2021, and the <b>S&amp;P 500</b> has put on a master class in outperforming expectations. Even with its pullback in recent days, the broad market index has gained nearly 30% this year, more than double its long-term historical average.</p>\n<p>Yet that just means we're another day closer to the inevitable market correction. Just as night follows day, a stock market crash is inevitable because market declines are a natural part of the normal business and investment cycle. No <a href=\"https://laohu8.com/S/AONE.U\">one</a> can forecast exactly when it will strike, but smart investors realize it's best to prepare for the eventuality.</p>\n<p>For as long as people have been investing, stretching even as far back to the Dutch tulip mania in the 1600s, busts have followed booms. And what a boom we've enjoyed! Since the bottom of the Great Recession, the S&amp;P 500 has quadrupled in value.</p>\n<p>2020's pandemic-driven 34% drop in the stock indexes within the span of just a few weeks was the worst on record. But savvy investors don't have to worry. These events are not a problem when you're invested in the right companies. Being prepared for the worst and hoping for the best means when the next stock market crash or correction occurs, you'll want to have your money invested in stocks that will help lead the way forward. Here are two tech stocks you'll want to buy.</p>\n<h2>1. Apple</h2>\n<p>The burden that inflation is imposing on consumers also poses a threat to some of the biggest, best-run businesses, like <b>Apple</b> (NASDAQ:AAPL), which is currently benefiting from the smartphone upgrade cycle and the rollout of 5G network infrastructure. Any attempt by the Federal Reserve to raise interest rates to contain runaway inflation could cause an economic slowdown by making money more expensive to borrow. Stock valuations would also turn lower.</p>\n<p>That's not necessarily bad news for investors who might find Apple's $2.8 trillion valuation a bit rich to buy into at the moment. The stock trades at 30 times trailing earnings, or about double its typical multiple. A correction would bring Apple back into the realm of the attainable, even as its business continues jogging forward.</p>\n<p>Sales of the iPhone 13 are outpacing those of the iPhone 12 at the same time, but Apple reportedly warned suppliers that demand is waning as the calendar year progresses. It's not necessarily for a lack of consumer desire, but rather the global supply chain constraints that have made it difficult to find the product. Apple previously cut its iPhone production target by 10 million units from its original goal of 90 million.</p>\n<p>Analysts think many consumers may choose to forgo the iPhone 13 and wait for the next upgrade. Coupled with a market crash, that could put Apple stock at a very attractive entry point with pent-up demand for the next iteration of the iPhone.</p>\n<h2>2. Amazon</h2>\n<p>Few companies are as essential to the working of the U.S. economy as <b>Amazon</b>&nbsp;(NASDAQ:AMZN). It will account for 41.4% of all online spending in the U.S. this year, according to eMarketer estimates. At the same time, Amazon Web Services (AWS), its cloud infrastructure business, is on track to generate over $60 billion in annual revenue in 2021 based on its year-to-date performance. The company is responsible for thousands of web-based businesses and the federal government's ability to remain online, making Amazon crucial to a well-functioning economy.</p>\n<p>That won't change if the stock market collapses. Its share of U.S. retail e-commerce sales will be more than 50% larger than the shares of the next nine e-commerce companies combined. Amazon's piece of the online market is nearly six times more than <b>Walmart</b>'s second-place share at just 7.2%, and 10 times greater than third-place <b><a href=\"https://laohu8.com/S/EBAY\">eBay</a></b>. E-commerce data tracker Edge by Ascential expects Amazon will see $26.7 billion just in online grocery sales five from now years, or nearly double its current amount.</p>\n<p>Amid rising prices and supply chain woes, Amazon has become a lifeline for many, and that will continue long after any financial restructuring. The stock gained 76% during the first year of the pandemic and took a breather during the reopening of the economy. Amazon shares have been relatively flat all year long. A correction would allow investors to buy a tech stock at a more reasonable valuation even as its crucial role only gets reinforced.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Top Tech Stocks to Buy During a Recession</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Top Tech Stocks to Buy During a Recession\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 10:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/2-top-tech-stocks-to-buy-during-a-recession/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>We're days away from the end of 2021, and the S&P 500 has put on a master class in outperforming expectations. Even with its pullback in recent days, the broad market index has gained nearly 30% ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/2-top-tech-stocks-to-buy-during-a-recession/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4170":"电脑硬件、储存设备及电脑周边","AAPL":"苹果","AMZN":"亚马逊","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4515":"5G概念","BK4553":"喜马拉雅资本持仓","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4524":"宅经济概念","BK4535":"淡马锡持仓","BK4538":"云计算","BK4559":"巴菲特持仓","BK4527":"明星科技股","BK4501":"段永平概念","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","BK4505":"高瓴资本持仓","BK4561":"索罗斯持仓","BK4548":"巴美列捷福持仓"},"source_url":"https://www.fool.com/investing/2021/12/24/2-top-tech-stocks-to-buy-during-a-recession/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193781141","content_text":"We're days away from the end of 2021, and the S&P 500 has put on a master class in outperforming expectations. Even with its pullback in recent days, the broad market index has gained nearly 30% this year, more than double its long-term historical average.\nYet that just means we're another day closer to the inevitable market correction. Just as night follows day, a stock market crash is inevitable because market declines are a natural part of the normal business and investment cycle. No one can forecast exactly when it will strike, but smart investors realize it's best to prepare for the eventuality.\nFor as long as people have been investing, stretching even as far back to the Dutch tulip mania in the 1600s, busts have followed booms. And what a boom we've enjoyed! Since the bottom of the Great Recession, the S&P 500 has quadrupled in value.\n2020's pandemic-driven 34% drop in the stock indexes within the span of just a few weeks was the worst on record. But savvy investors don't have to worry. These events are not a problem when you're invested in the right companies. Being prepared for the worst and hoping for the best means when the next stock market crash or correction occurs, you'll want to have your money invested in stocks that will help lead the way forward. Here are two tech stocks you'll want to buy.\n1. Apple\nThe burden that inflation is imposing on consumers also poses a threat to some of the biggest, best-run businesses, like Apple (NASDAQ:AAPL), which is currently benefiting from the smartphone upgrade cycle and the rollout of 5G network infrastructure. Any attempt by the Federal Reserve to raise interest rates to contain runaway inflation could cause an economic slowdown by making money more expensive to borrow. Stock valuations would also turn lower.\nThat's not necessarily bad news for investors who might find Apple's $2.8 trillion valuation a bit rich to buy into at the moment. The stock trades at 30 times trailing earnings, or about double its typical multiple. A correction would bring Apple back into the realm of the attainable, even as its business continues jogging forward.\nSales of the iPhone 13 are outpacing those of the iPhone 12 at the same time, but Apple reportedly warned suppliers that demand is waning as the calendar year progresses. It's not necessarily for a lack of consumer desire, but rather the global supply chain constraints that have made it difficult to find the product. Apple previously cut its iPhone production target by 10 million units from its original goal of 90 million.\nAnalysts think many consumers may choose to forgo the iPhone 13 and wait for the next upgrade. Coupled with a market crash, that could put Apple stock at a very attractive entry point with pent-up demand for the next iteration of the iPhone.\n2. Amazon\nFew companies are as essential to the working of the U.S. economy as Amazon (NASDAQ:AMZN). It will account for 41.4% of all online spending in the U.S. this year, according to eMarketer estimates. At the same time, Amazon Web Services (AWS), its cloud infrastructure business, is on track to generate over $60 billion in annual revenue in 2021 based on its year-to-date performance. The company is responsible for thousands of web-based businesses and the federal government's ability to remain online, making Amazon crucial to a well-functioning economy.\nThat won't change if the stock market collapses. Its share of U.S. retail e-commerce sales will be more than 50% larger than the shares of the next nine e-commerce companies combined. Amazon's piece of the online market is nearly six times more than Walmart's second-place share at just 7.2%, and 10 times greater than third-place eBay. E-commerce data tracker Edge by Ascential expects Amazon will see $26.7 billion just in online grocery sales five from now years, or nearly double its current amount.\nAmid rising prices and supply chain woes, Amazon has become a lifeline for many, and that will continue long after any financial restructuring. The stock gained 76% during the first year of the pandemic and took a breather during the reopening of the economy. Amazon shares have been relatively flat all year long. A correction would allow investors to buy a tech stock at a more reasonable valuation even as its crucial role only gets reinforced.","news_type":1},"isVote":1,"tweetType":1,"viewCount":758,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876744197,"gmtCreate":1637369731357,"gmtModify":1637369731497,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583127455388557","authorIdStr":"3583127455388557"},"themes":[],"htmlText":"Innovation has bought Nvidea to next level !","listText":"Innovation has bought Nvidea to next level !","text":"Innovation has bought Nvidea to next level !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876744197","repostId":"1154597314","repostType":4,"repost":{"id":"1154597314","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637334223,"share":"https://www.laohu8.com/m/news/1154597314?lang=&edition=full","pubTime":"2021-11-19 23:03","market":"us","language":"en","title":"Nvidia shares rose more than 3% to a new high","url":"https://stock-news.laohu8.com/highlight/detail?id=1154597314","media":"Tiger Newspress","summary":"Nvidia shares rose more than 3% to a new high.One of the most anticipated companies to report earnings this week, Nvidia once again beat consensus. NVDA stock’s popularity has skyrocketed and now trades like a meme.","content":"<p>Nvidia shares rose more than 3% to a new high.One of the most anticipated companies to report earnings this week, Nvidia once again beat consensus. NVDA stock’s popularity has skyrocketed and now trades like a meme.</p>\n<p><img src=\"https://static.tigerbbs.com/c21969667d27e754ab8088731dcce7d0\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia shares rose more than 3% to a new high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia shares rose more than 3% to a new high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-19 23:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nvidia shares rose more than 3% to a new high.One of the most anticipated companies to report earnings this week, Nvidia once again beat consensus. NVDA stock’s popularity has skyrocketed and now trades like a meme.</p>\n<p><img src=\"https://static.tigerbbs.com/c21969667d27e754ab8088731dcce7d0\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154597314","content_text":"Nvidia shares rose more than 3% to a new high.One of the most anticipated companies to report earnings this week, Nvidia once again beat consensus. NVDA stock’s popularity has skyrocketed and now trades like a meme.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1364,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873484857,"gmtCreate":1636977061839,"gmtModify":1636977237042,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583127455388557","authorIdStr":"3583127455388557"},"themes":[],"htmlText":"Active invesrment is better than passive investment. You may plan to fight with Mr Market ahead","listText":"Active invesrment is better than passive investment. You may plan to fight with Mr Market ahead","text":"Active invesrment is better than passive investment. You may plan to fight with Mr Market ahead","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873484857","repostId":"2183046479","repostType":4,"repost":{"id":"2183046479","kind":"highlight","pubTimestamp":1636962804,"share":"https://www.laohu8.com/m/news/2183046479?lang=&edition=full","pubTime":"2021-11-15 15:53","market":"us","language":"en","title":"Cathie Wood Goes Dumpster Diving: 3 Stocks She Just Bought","url":"https://stock-news.laohu8.com/highlight/detail?id=2183046479","media":"Motley Fool","summary":"A trio of stocks you might consider adding to your portfolio.","content":"<p>Cathie Wood runs one(AONE.U) of the most popular tech stock funds, the <b>ARK Innovation Fund </b>(NYSEMKT:ARKK), with more than $19 billion under management. This fund is not only popular, but it is also soundly beating the <b>S&amp;P 500</b> with a five-year return of 39% annually (as of Sept. 30).&nbsp;Cathie Wood runs this fund and seven other tech-focused funds that are popular with growth investors. One of the things that makes her a popular investor to follow is that all the buys and sells from these funds are published daily.</p>\n<p>Since she has a history of picking high-tech stocks at good prices, we asked three Motley Fool contributors to highlight one company that her funds have purchased recently that investors should consider adding to their portfolio.</p>\n<p>They came up with <b><a href=\"https://laohu8.com/S/FB\">Meta Platforms</a> </b>(NASDAQ:FB), <b>Palantir</b> (NYSE:PLTR), and <b>Twilio</b> (NYSE:TWLO).</p>\n<h2>Meta Platforms: The company formerly known as Facebook</h2>\n<p><b>Danny Vena (Meta Platforms): </b>The <b><a href=\"https://laohu8.com/S/ARKF\">ARK Fintech Innovation ETF</a></b> has made some bold moves lately, no doubt spurred on by Cathie Wood's vision of the future. One of the biggest purchases over the past week is the addition of a big chunk of Meta Platforms, the company formerly known as Facebook.</p>\n<p>Over the past week, the fund has stockpiled more than 100,000 shares of Meta, worth more than $33 million (as of this writing). Perhaps more importantly, ARK Fintech Innovation already had a substantial stake in Meta, now equal to a roughly 3% position, and valued at nearly $103 million -- making it the fund's 11th largest position.</p>\n<p>Meta has been working to debut its long-awaited digital currency dubbed Diem, formerly known as Libra. The company is a founding member of the Diem Association, which underpins the upcoming cryptocurrency.&nbsp;Diem is a blockchain-based payment system that was designed from the ground up with payments in mind, focusing on \"consumer safety, financial stability, and combating financial crime.\"</p>\n<p>Additionally, just last month, Meta launched a pilot of Novi -- its cryptocurrency wallet -- to a small number of users in the U.S. and Guatemala.</p>\n<p>Given Wood's early adoption and bullish track record regarding <b>Bitcoin</b>, it's little wonder the rock star investor might place a similar bet on a Meta-backed cryptocurrency and digital wallet. But those fintech aspirations notwithstanding, there are plenty of other reasons to be bullish on Meta.</p>\n<p>Let's not forget that Facebook is one of the most recognized companies on the planet. For the third quarter, Facebook reported 1.93 billion daily active users (DAUs), up 6% year over year, and 2.91 billion monthly active users (MAUs). When you expand that to include the company's other platforms (Instagram, WhatsApp, and Messenger) that rises to 2.81 billion DAUs and 3.58 billion MAUs.</p>\n<p>That many users creates a powerful network effect for the social media baron, helping Meta generate significant advertising revenue to support its moonshots. In the third quarter, revenue of $29 billion grew 35% year over year -- even as the company dealt with privacy reforms rolled out by <b>Apple</b>, which made it more difficult to measure the success of advertising campaigns across devices using iOS. Meta also generated more than $9.1 billion in net income and $9.5 billion in free cash flow.</p>\n<p>Even as the company faces regulatory challenges, Meta is preparing for the metaverse, a digital realm online where users play, work, and shop. Meta describes this as \"the next evolution of social connection ... [where] you'll be able to socialize, learn, collaborate and play in ways that go beyond what's possible today.\"</p>\n<p>Meta sees the metaverse as its next big growth driver, as well as a way to retain young, tech savvy users. The company has a head start in the areas of augmented reality (AR) and virtual-reality, which will likely be key components in its broader strategy.</p>\n<p>It also doesn't hurt that the stock is on sale at a 15% discount to recent highs.</p>\n<h2>Palantir: Wood continues adding shares to this insight seeker</h2>\n<p><b>Will Healy</b> <b>(Palantir): </b>Palantir stands out from other data companies in that it specializes in delivering insights. The company works with national security and law enforcement organizations through its Gotham software, functionality that has everyone talking about Palantir stock.</p>\n<p>Moreover, the company has also developed a product for the commercial space, called Foundry, which currently drives the company's fastest growth.</p>\n<p>Seeing the potential of these products, Wood has accumulated Palantir shares in the ARK Innovation Fund since February, buying multiple lots with only one sale in September. This has taken the total in that fund to more than 24 million shares, a 2.8% weighting. Wood has added Palantir shares less aggressively to the <b>ARK Industrial Innovation ETF</b>. Nonetheless, more than 1.1 million Palantir shares make up about 1% of this fund.</p>\n<p>Palantir reported strong numbers in its third-quarter 2021 earnings report. Third-quarter revenue of $392 million surged 36% from year-ago levels. This led to an adjusted net income of $82 million. Palantir also raised fourth-quarter guidance, and predicted the $418 million in revenue will rise 30% year over year if that number holds.</p>\n<p>Nonetheless, the stock dropped 9% in Tuesday trading as the company forecast an adjusted operating margin of 22% for Q4. Analysts had expected 24%. Moreover, a government document indicated that U.S. Immigration and Customs Enforcement (ICE) might replace Palantir's system with a competing product, though a recent U.S. Army contract could mitigate that loss.</p>\n<p>Additionally, while Wood bought just under 1 million shares between the two funds on that day, the stock fell an additional 7% on Wednesday. With that move, Palantir stock wipes out all of its 2021 gains and has fallen 4% in 2021 as of the time of this writing. Also, despite that drop, Palantir trades at a price-to-sales (P/S) ratio of 27, well above the average S&amp;P 500 stock, which sells at just over three times sales.</p>\n<p>With its data insight capabilities, Palantir's massive revenue growth should continue. However, given the high sales multiple and the stock falling on a mostly favorable earnings report, investors may not want to follow Wood's lead in the near term.</p>\n<h2>Twilio: Expanding its mission</h2>\n<p><b>Brian Withers (Twilio): </b>Twilio announced earnings on Oct. 28, and the stock took a 17% haircut the next day. Since then, Cathie Wood's ARK funds snapped up over 415,000 shares of the stock representing about $122 million. These buys moved this customer communication platform specialist to the 12th largest holding across its funds. Let take a look at why she might be buying massive quantities of this tech company, which appears to be on sale.</p>\n<p>First, let's look at the quarterly results and why investors may have been spooked. The top line grew at a massive 65% year over year, but subtracting the contributions for the Zipwhip and Segment.io acquisitions, the year-over-year growth drops to 38%. This is a deceleration from the last four quarters of organic year-over-year growth that were between 47% and 54%. This slowdown was one reason for the stock sell-off, the other was likely the growing losses. Expenses increased faster than revenue this quarter and the company more than doubled its operating loss year over year.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metrics</p></th>\n   <th><p>Q3 2020</p></th>\n   <th><p>Q2 2021</p></th>\n   <th><p>Q3 2021</p></th>\n   <th><p>Change (QOQ)</p></th>\n   <th><p>Change (YOY)</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td><p>Revenue</p></td>\n   <td><p>$448 million</p></td>\n   <td><p>$669 million</p></td>\n   <td><p>$740 million</p></td>\n   <td><p>11%</p></td>\n   <td><p>65%</p></td>\n  </tr>\n  <tr>\n   <td><p>Organic revenue</p></td>\n   <td><p>$438 million</p></td>\n   <td><p>$590 million</p></td>\n   <td><p>$606 million</p></td>\n   <td><p>3%</p></td>\n   <td><p>38%</p></td>\n  </tr>\n  <tr>\n   <td><p>Operating income (loss)</p></td>\n   <td><p>($112 million)</p></td>\n   <td><p>($227 million)</p></td>\n   <td><p>($232 million)</p></td>\n   <td><p>n/a</p></td>\n   <td><p>n/a</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Company earnings release. QOQ = quarter over quarter. YOY = year over year.</p>\n<p>But one quarter doesn't make a trend and this company's got a lot up its sleeve. It just announced its Twilio Engage platform which takes advantage of the integration of Segment.io's customer data platform and Twilio's core messaging services. This new product will enable businesses to personalize messages based on customer behaviors and will make the messages customers receive even more relevant to their needs.</p>\n<p>Lastly, the company has updated its mission. For the last 13 years, the mission has been \"Fuel the Future of Communications.\" Today the mission is broader, focusing on its core user, the software developer. It is to \"Unlock the Imagination of Builders.\" This may not make any impact this quarter or even in the coming year. But over time, this allows the company to expand beyond just its communication products.</p>\n<p>With the stock more than 30% off its high, it could be a good time to jump in and pick up some shares yourself. You probably won't be buying in the amount that the ARK funds have, but even if you just add a few shares today, in five years, it's likely you'll be very happy you did.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Goes Dumpster Diving: 3 Stocks She Just Bought</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Goes Dumpster Diving: 3 Stocks She Just Bought\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-15 15:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/14/cathie-wood-goes-dumpster-diving-3-stocks-she-just/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cathie Wood runs one(AONE.U) of the most popular tech stock funds, the ARK Innovation Fund (NYSEMKT:ARKK), with more than $19 billion under management. This fund is not only popular, but it is also ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/14/cathie-wood-goes-dumpster-diving-3-stocks-she-just/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWLO":"Twilio Inc","PLTR":"Palantir Technologies Inc."},"source_url":"https://www.fool.com/investing/2021/11/14/cathie-wood-goes-dumpster-diving-3-stocks-she-just/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2183046479","content_text":"Cathie Wood runs one(AONE.U) of the most popular tech stock funds, the ARK Innovation Fund (NYSEMKT:ARKK), with more than $19 billion under management. This fund is not only popular, but it is also soundly beating the S&P 500 with a five-year return of 39% annually (as of Sept. 30). Cathie Wood runs this fund and seven other tech-focused funds that are popular with growth investors. One of the things that makes her a popular investor to follow is that all the buys and sells from these funds are published daily.\nSince she has a history of picking high-tech stocks at good prices, we asked three Motley Fool contributors to highlight one company that her funds have purchased recently that investors should consider adding to their portfolio.\nThey came up with Meta Platforms (NASDAQ:FB), Palantir (NYSE:PLTR), and Twilio (NYSE:TWLO).\nMeta Platforms: The company formerly known as Facebook\nDanny Vena (Meta Platforms): The ARK Fintech Innovation ETF has made some bold moves lately, no doubt spurred on by Cathie Wood's vision of the future. One of the biggest purchases over the past week is the addition of a big chunk of Meta Platforms, the company formerly known as Facebook.\nOver the past week, the fund has stockpiled more than 100,000 shares of Meta, worth more than $33 million (as of this writing). Perhaps more importantly, ARK Fintech Innovation already had a substantial stake in Meta, now equal to a roughly 3% position, and valued at nearly $103 million -- making it the fund's 11th largest position.\nMeta has been working to debut its long-awaited digital currency dubbed Diem, formerly known as Libra. The company is a founding member of the Diem Association, which underpins the upcoming cryptocurrency. Diem is a blockchain-based payment system that was designed from the ground up with payments in mind, focusing on \"consumer safety, financial stability, and combating financial crime.\"\nAdditionally, just last month, Meta launched a pilot of Novi -- its cryptocurrency wallet -- to a small number of users in the U.S. and Guatemala.\nGiven Wood's early adoption and bullish track record regarding Bitcoin, it's little wonder the rock star investor might place a similar bet on a Meta-backed cryptocurrency and digital wallet. But those fintech aspirations notwithstanding, there are plenty of other reasons to be bullish on Meta.\nLet's not forget that Facebook is one of the most recognized companies on the planet. For the third quarter, Facebook reported 1.93 billion daily active users (DAUs), up 6% year over year, and 2.91 billion monthly active users (MAUs). When you expand that to include the company's other platforms (Instagram, WhatsApp, and Messenger) that rises to 2.81 billion DAUs and 3.58 billion MAUs.\nThat many users creates a powerful network effect for the social media baron, helping Meta generate significant advertising revenue to support its moonshots. In the third quarter, revenue of $29 billion grew 35% year over year -- even as the company dealt with privacy reforms rolled out by Apple, which made it more difficult to measure the success of advertising campaigns across devices using iOS. Meta also generated more than $9.1 billion in net income and $9.5 billion in free cash flow.\nEven as the company faces regulatory challenges, Meta is preparing for the metaverse, a digital realm online where users play, work, and shop. Meta describes this as \"the next evolution of social connection ... [where] you'll be able to socialize, learn, collaborate and play in ways that go beyond what's possible today.\"\nMeta sees the metaverse as its next big growth driver, as well as a way to retain young, tech savvy users. The company has a head start in the areas of augmented reality (AR) and virtual-reality, which will likely be key components in its broader strategy.\nIt also doesn't hurt that the stock is on sale at a 15% discount to recent highs.\nPalantir: Wood continues adding shares to this insight seeker\nWill Healy (Palantir): Palantir stands out from other data companies in that it specializes in delivering insights. The company works with national security and law enforcement organizations through its Gotham software, functionality that has everyone talking about Palantir stock.\nMoreover, the company has also developed a product for the commercial space, called Foundry, which currently drives the company's fastest growth.\nSeeing the potential of these products, Wood has accumulated Palantir shares in the ARK Innovation Fund since February, buying multiple lots with only one sale in September. This has taken the total in that fund to more than 24 million shares, a 2.8% weighting. Wood has added Palantir shares less aggressively to the ARK Industrial Innovation ETF. Nonetheless, more than 1.1 million Palantir shares make up about 1% of this fund.\nPalantir reported strong numbers in its third-quarter 2021 earnings report. Third-quarter revenue of $392 million surged 36% from year-ago levels. This led to an adjusted net income of $82 million. Palantir also raised fourth-quarter guidance, and predicted the $418 million in revenue will rise 30% year over year if that number holds.\nNonetheless, the stock dropped 9% in Tuesday trading as the company forecast an adjusted operating margin of 22% for Q4. Analysts had expected 24%. Moreover, a government document indicated that U.S. Immigration and Customs Enforcement (ICE) might replace Palantir's system with a competing product, though a recent U.S. Army contract could mitigate that loss.\nAdditionally, while Wood bought just under 1 million shares between the two funds on that day, the stock fell an additional 7% on Wednesday. With that move, Palantir stock wipes out all of its 2021 gains and has fallen 4% in 2021 as of the time of this writing. Also, despite that drop, Palantir trades at a price-to-sales (P/S) ratio of 27, well above the average S&P 500 stock, which sells at just over three times sales.\nWith its data insight capabilities, Palantir's massive revenue growth should continue. However, given the high sales multiple and the stock falling on a mostly favorable earnings report, investors may not want to follow Wood's lead in the near term.\nTwilio: Expanding its mission\nBrian Withers (Twilio): Twilio announced earnings on Oct. 28, and the stock took a 17% haircut the next day. Since then, Cathie Wood's ARK funds snapped up over 415,000 shares of the stock representing about $122 million. These buys moved this customer communication platform specialist to the 12th largest holding across its funds. Let take a look at why she might be buying massive quantities of this tech company, which appears to be on sale.\nFirst, let's look at the quarterly results and why investors may have been spooked. The top line grew at a massive 65% year over year, but subtracting the contributions for the Zipwhip and Segment.io acquisitions, the year-over-year growth drops to 38%. This is a deceleration from the last four quarters of organic year-over-year growth that were between 47% and 54%. This slowdown was one reason for the stock sell-off, the other was likely the growing losses. Expenses increased faster than revenue this quarter and the company more than doubled its operating loss year over year.\n\n\n\nMetrics\nQ3 2020\nQ2 2021\nQ3 2021\nChange (QOQ)\nChange (YOY)\n\n\n\n\nRevenue\n$448 million\n$669 million\n$740 million\n11%\n65%\n\n\nOrganic revenue\n$438 million\n$590 million\n$606 million\n3%\n38%\n\n\nOperating income (loss)\n($112 million)\n($227 million)\n($232 million)\nn/a\nn/a\n\n\n\nData source: Company earnings release. QOQ = quarter over quarter. YOY = year over year.\nBut one quarter doesn't make a trend and this company's got a lot up its sleeve. It just announced its Twilio Engage platform which takes advantage of the integration of Segment.io's customer data platform and Twilio's core messaging services. This new product will enable businesses to personalize messages based on customer behaviors and will make the messages customers receive even more relevant to their needs.\nLastly, the company has updated its mission. For the last 13 years, the mission has been \"Fuel the Future of Communications.\" Today the mission is broader, focusing on its core user, the software developer. It is to \"Unlock the Imagination of Builders.\" This may not make any impact this quarter or even in the coming year. But over time, this allows the company to expand beyond just its communication products.\nWith the stock more than 30% off its high, it could be a good time to jump in and pick up some shares yourself. You probably won't be buying in the amount that the ARK funds have, but even if you just add a few shares today, in five years, it's likely you'll be very happy you did.","news_type":1},"isVote":1,"tweetType":1,"viewCount":696,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873965620,"gmtCreate":1636846358632,"gmtModify":1636846358632,"author":{"id":"3583127455388557","authorId":"3583127455388557","name":"SunHao","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3583127455388557","authorIdStr":"3583127455388557"},"themes":[],"htmlText":"Phizer is riding on pandamic wave to boost their revenue&nbsp;","listText":"Phizer is riding on pandamic wave to boost their revenue&nbsp;","text":"Phizer is riding on pandamic wave to boost their revenue","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873965620","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p>\n<p>“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p>\n<p>Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p>\n<p>Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p>\n<p>In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p>\n<p>The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p>\n<p>Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p>\n<p>The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p>\n<p>The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p>\n<p>The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p>\n<p>While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p>\n<p>In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p>\n<p>The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p>\n<p>“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p>\n<p>Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p>\n<p>“[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p>\n<p>The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p>\n<p>“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p>\n<p>Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p>\n<p>“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p>\n<p>Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p>\n<p>“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p>\n<p>That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p>\n<p>Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p>\n<p>Moderna shares are down more than 40% over the past three months.</p>\n<p>As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p>\n<p>When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p>\n<p>That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p>\n<p>Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p>\n<p>Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p>\n<p>An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that...</p>\n\n<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1306,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}